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Background: Human embryonic stem cells (hESCs) are pluripotent cells derived 
from in vitro fertilized (IVF) embryos. Because of their origin in healthy human 
tissues, self-renewability and differentiate capability, hESCs can potentially be 
adopted as a biological model for toxicity study. To date, wide use of hESCs in 
cytotoxicity and DNA damage study has been restricted by technical limitations. One 
such limitation is from MEF feeder cells. Although MEF help maintain cultured 
hESCs in there undifferentiated status, they nevertheless become a form of 
contamination when pure populations of hESCs are intended to be harvested for 
various analyses. Meanwhile, reactive oxygen species (ROS) are known to play an 
important role in physiological and pathophysiological processes during embryo 
development. 
 
Hypotheses: Effective cytotoxicity and DNA damage study can be enabled through 
the development of a feeder-cell-free hESC culture system. Because of the drastically 
different cell physiology between pluripotent hESCs and differentiated cells, their 
cytotoxicity and DNA damage responses upon ROS challenge could be distinct and 
regulated differently by underlying molecular mechanisms. 
 
Methods: An autologous feeder-cell-free system was developed for the cultivation of 
undifferentiated hESCs. Fibroblastic-like cells were derived from hESCs as a model 




generating system. Cytotoxicity and DNA damage of H2O2-treated hESCs and 
differentiated cells were studied. 
 
Results: Extracellular matrix (ECM) was extracted from fibroblast-like cells which 
were differentiated from hESCs. The ECM coating was capable of supporting 
undifferentiated growth of hESCs and excluded MEF cells from the culture system. 
Feeder-free-cultured hESCs and hESC-derived fibroblast-like cells were used to study 
H2O2-induced cytotoxicity and DNA damage. In comparison with differentiated cells, 
higher induction of intracellular ROS was observed in H2O2-treated hESCs. DNA 
synthesis was more intensively inhibited in hESCs, which was also accompanied by 
higher induction of apoptosis. However, DNA damage was found to be lower in 
hESCs. Genes involved in DNA damage signaling pathway were more readily 
expressed in hESCs. 
 
Conclusion: The autologous feeder-cell-free hESC cultivation system made the use 
of hESCs in toxicity study more feasible. Cytotoxicity and DNA damage study of 
ROS showed that pluripotent hESCs had unique damage responses.
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  At the dawn of the 20th century, Jacques Loeb’s work on artificial parthenogenesis 
successfully activated sea urchin eggs in vitro: change of salt concentration in sea 
water or ultra-violet irradiation initiates embryogenesis of unfertilized egg (Loeb 
1914). This discovery represents an early example of bioengineering at work and laid 
foundation for two branches of modern biosciences: developmental biology and in 
vitro fertilization (IVF) (Weissmann 2006). Meanwhile, the laboratory attempt to 
“control life” also caused public debate at that time. 
  Decades later now, human embryonic stem cell (hESC) research is caught up in a 
similar situation like parthenogenesis before it: first, hESCs raise ethical concern 
because they originate from discarded IVF embryos; second, using hESCs for tissue 
engineering and regenerative medicine is considered by some as an attempt to play 
god and “control life” (Maienschein 2009). These two issues of hESCs have been 
generating philosophical and theological controversies. 
  While hESC research has been attracting scientists and funding with the promise to 
deliver cures for diseases in the future, adequate understanding of stem cell 
physiology may be a prerequisite for rationalized use of hESCs (Lenas et al. 2009). 
The premature termination of world’s first hESC-based clinical trial by Geron 
Corporation reminded us that rushing into cell therapies and products with incomplete 
knowledge on relevant biology is often no guarantee to success. This observation may 
also apply to other proposed applications of hESCs, such as disease-related research, 
developmental biology and toxicology research. 
  In the following literature review, backgrounds of hESCs are introduced in 
comparison with other types of pluripotent stem cells. Reported methods for hESC 
cultivation and use of embryonic stem cells (ESCs) in toxicology are introduced. In 
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addition, challenges before successful adoption of hESCs in toxicology research are 
summarized. 
 
1.1 Pluripotent stem cells 
  Because of historical reasons and the abundance of relevant publications, the concept 
of mammalian pluripotent stem cells is usually introduced using mouse as the model 
organism. Embryogenesis begins from the zygote. Zygote is totipotent for they give 
rise to all cells of an organism. As the zygote develops, cell specialization occurs. 
Embryonic tissues differentiate into trophoblast and inner cell mass (ICM). 
Trophoblast eventually forms placenta, and ICM gives rise to epiblast and hyphoblast. 
Epiblast and hyphoblast subsequently form embryo proper and yolk sac respectively. 
Pluripotency is used to describe the ability of ICM and epiblast to generate all somatic 
and germline cells (Figure 1). Pluripotent cells are less plastic than totipotent cells, as 
ICM and epiblast cannot give rise to trophoblast. 
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Figure 1: Schematic diagram showing early developmental stages of mouse embryos. 
Pluripotent stem cells are derived from either ICM (preimplantation) or epiblast 
(postimplantation). 
 
  Historically, pluripotent stem cell lines were first obtained from murine teratoma. 
Following that discovery, other types of pluripotent stem cells were derived from 
healthy tissues at early stages of embryogenesis. These pluripotent stem cells include: 
ESCs from ICM at blastocyst stage (Evans and Kaufman 1981;Martin 1981), epiblast 
stem cells (EpiSCs) (Tesar et al. 2007;Brons et al. 2007), embryonic germ cells from 
primordial germ cells (PGC) (Surani 1999), and spermatogonial germ stem cells from 
neonatal male testis (Kanatsu-Shinohara et al. 2004).  
  An alternative method to obtain pluripotent stem cells is through somatic cell nuclear 
reprogramming. So far, somatic cell nuclear reprogramming can be achieved through 
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three techniques: somatic cell nuclear transfer (SCNT), cell fusion, and direct 
reprogramming into induced pluripotent stem cells (iPSCs) with defined factors. 
  An overview of different pluripotent stem cells is given in the following sections. 
 
1.1.1 Embryonal carcinoma cells 
  To the best of the candidate’s knowledge, the first mammalian pluripotent stem cell 
line was embryonal carcinoma cells derived around 1970 by Leroy Stevens. In 1953, 
Stevens observed teratoma formation in mouse testicles while studying tobacco and 
cancer. The teratoma ectopically contained unorganized cartilage, teeth, and hair 
tissues. Soon, embryonal carcinoma cells were successfully cultivated in vitro and 
their teratoma formation ability remained intact (Kleinsmith and Pierce 1964;Pierce et 
al. 1967). Embryonal carcinoma cells were called “pluripotent stem cells” for the 
ability to differentiate into tissues from all three germ layers (ectoderm, mesoderm 
and endoderm) of the embryo proper. However, the chromosomal status of embryonal 
carcinoma cells is abnormal, because of its cancerous nature. 
  Embryonal carcinoma cell research revealed a key property of pluripotent stem cells: 
giving the right environment, they can differentiate into various cell types in vitro 
without generating the entire organism in petri dishes. This lay the foundation for 
future application of pluripotent stem cells in toxicology by circumventing the 
bioethical dilemma of exposing conscious organisms to harmful conditions. 
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1.1.1.2 Embryonic germ cells and adult germline stem cells 
  Pluripotent cells with normal chromosome status can be obtained from germline 
tissues. When suitable in vitro condition is provided, primordial germ cells harvested 
from mouse embryos at embryonic day 8.5 give rise to pluripotent cell lines. These 
cell lines are termed embryonic germ cells (Surani 1999). They are capable of 
forming teratomas and contributing to chimera. Unlike ESCs, embryonic germ cells 
trigger demethylation of somatic imprinted genes when fused with somatic cells. This 
property echoes with the physiological primordial germ cell development. Embryonic 
germ cells can also be derived from human fetuses. But characteristics of human 
embryonic germ cells are poorly defined at this point (Shamblott et al. 1998). 
  Alternatively, germline stem cells can be generated from newborn and adult 
testicular tissues. These ESC-like cells are named as adult germline stem cells. Adult 
germline stem cells share key features with ESCs but carry a male-specific gene 
imprinting pattern (Kanatsu-Shinohara et al. 2004). Human adult germline stem cells 
can also be generated from male testes (Conrad et al. 2008). However, the identity of 
human adult germline stem cells has been questioned (Ko et al. 2010). 
 
1.1.3 Epiblast stem cells (EpiSCs) 
  While ESCs are derived from preimplantation embryo, EpiSCs originate from ICM 
of postimplantation embryo. EpiSCs are derived by explanting epiblast at embryonic 
day 5.5-7.5 and growing the cells with supplementation of basic fibroblast growth 
factor (FGF2) and Activin (Tesar et al. 2007;Brons et al. 2007). EpiSCs express 
pluripotent markers, and are capable of forming embryoid body (EB) in vitro and 
Introduction and Literature Review 
7 
 
teratoma in vivo. In comparison with mouse embryonic stem cells (mESCs), EpiSCs 
have low chimera formation efficiency and are inactivated X chromosome. 
  Interestingly, pluripotency of EpiSCs is positively regulated by transforming growth 
factor beta (TGFβ), FGF2, Activin and extracellular-signal-regulated kinases (ERK)-
1/2, whereas the pluripotency of mESCs is inhibited by TGFβ, FGF2, Activin and 
ERK-1/2. Regarding molecular biology identities, EpiSCs share a gene expression 
profile resembling postimplantation epiblast, rather than that of the ICM. Reduced 
expression of the transcription factors like Nanog, Rex1 and Klf are found in EpiSCs 
in comparison with mESCs. Differentiation markers such as FGF5, major 
histocompatibility complex (MHC) class I are already expressed in EpiSCs but not in 
mESCs. 
 
1.1.4 Pluripotent stem cells derived by epigenetic reprogramming 
  Apart from direct harvesting primary tissues, pluripotent stem cells can also be 
derived by epigenetic reprogramming. 
  Somatic cells can be reprogrammed into a pluripotent-like status by three methods: 
SCNT, cell fusion and direct reprogramming with defined factors (Yamanaka and 
Blau 2010;Jaenisch and Young 2008). In SCNT and cell fusion, the developmental 
program of somatic cell was ‘reset’ to an ESC-like pluripotent state in a one-step 
fashion. Direct reprogramming however takes a more progressive process to reset the 
developmental clock (Hanna et al. 2009a). 
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1.1.4.1 Somatic cell nuclear transfer (SCNT) 
  In SCNT, reprogramming is initiated by transplanting somatic cell nuclear into an 
enucleated oocyte. Mechanistically, it demonstrates that all genetic information 
required to produce an entire organism is available in differentiated cells. Only the 
activation of these information is triggered by the nuclear transplantation (Eggan et al. 
2004;Hochedlinger and Jaenisch 2002). This activation is presumably manifested by 
reprogramming factors present in cytoplasm of the oocyte. 
  SCNT can lead to cloning of the entire organism. The first successful case of 
mammalian cloning was Dolly the sheep in 1997 (Wilmut et al. 2007;Wilmut et al. 
1997). This breakthrough was followed by cloned mice (Wakayama et al. 1998) and a 
range of other animals. It is worth noting that cloning efficiency is constantly low (1-
2% for mice) in all species (Thuan et al. 2010). 
  Cloned mice carry abnormalities including aberrant gene expression, telomere 
elongation, impaired immune system and increased susceptibility to cancer (Thuan et 
al. 2010). These abnormalities raised concerns that mESCs generated by SCNT may 
not equal to ICM-derived mESCs. Indeed, it was found that reprogramming through 
SCNT is often incomplete and the resulted mESCs carry “epigenetic memories” of 
somatic cells (Simonsson and Gurdon 2004). Such defects may undermine the 
usefulness of SCNT-derived hESC in both clinical and non-clinical applications. 
 
1.1.4.2 Cell fusion 
  Cell fusion, as its name suggests, involves fusing two or more cells together to form 
a new cell. Originally, it was found that thymocytes acquired a pluripotent-like state 
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after being fused with mESCs (Tada et al. 2001). Soon after, somatic human cells 
were also successfully reprogrammed though fusion with hESCs (Cowan et al. 2005). 
  However pluripotent cells generated through fusion are tetraploid instead of diploid. 
The tetraploidy may lead to limited clinical use of fused cells. It is also possible to 
derive interspecies hybrid cells called heterokaryons through fusion. Heterokaryons 
are valuable tools for mechanistic study of reprogramming, as the progression and 
mechanism of reprogramming can be more easily monitored by inter-species 
differences (Bhutani et al. 2010;Pereira et al. 2008). 
 
1.1.4.3 Induced pluripotent stem cells (iPSCs) 
  Shinya Yamanaka and colleagues first showed in 2006 that by overexpressing four 
defined transcription factors (Oct-4, Sox-2, Klf4 and c-MYC) in mouse fibroblasts, 
induced pluripotent stem cells (iPSCs) can be generated (Takahashi and Yamanaka 
2006). These iPSCs are pluripotent and capable of forming chimaeras and germline 
transmission (Okita et al. 2007;Wernig et al. 2007). Human iPSCs were also derived 
after mouse iPSCs (Yu et al. 2007;Takahashi et al. 2007). 
  Since 2006, techniques to generate iPSCs have been greatly improved. These 
improvements include: new and/or simpler combinations of reprogramming factors 
(e.g. a Oct-4, Sox-2, Nanog, Lin-28); generation of iPSCs from other types of somatic 
cells (e.g. from pancreatic β cells, keratinocytes, hepatocytes); using non-viral, non-
genome-integrated methods to introduce reprogramming factors; and improved 
reprogramming efficiency (González et al. 2011). 
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  Despite a high demand to generate patient-specific and disease-modeled iPSCs, it 
was found that iPSCs are not identical to ESCs. For example, iPSCs carry some 
epigenetic signature of somatic cells and sometimes do not respond to differentiation 
signals (Kim et al. 2010;Lister et al. 2011). In-depth investigations are needed to 
uncover the reprogramming mechanism. 
 
1.1.5 Embryonic stem cells (ESCs) 
1.1.5.1 Mouse embryonic stem cells (mESCs) 
  Historically, mESCs are the first mammalian pluripotent stem cell derived from 
healthy tissues (Martin 1981;Evans and Kaufman 1981). To date, mESCs have 
become an important tool for mammalian gene function research. Key characteristics 
of mESCs include: domed colony shape, high single-cell clonogenicity, pre-
inactivation X chromosomes and pluripotency negatively regulated by 
TGFβ/FGF2/Activin/ERK-1/2 signaling (Nichols and Smith 2009).  
  Interestingly, mESCs can only be derived from certain mouse strains such as 129, 
BALB/C and C57BL/6, but not from other strains. Isolation and in vitro cultivation of 
ICM from mESC-denied mouse strains or rats generate EpiSCs rather than mESCs 
(Buehr et al. 2008). Hanna et al. showed that EpiSCs can revert back to a mESC-like 
state by: promoting leukemia inhibitory factor (LIF) and Stat3 signaling; inhibiting 
FGF2 and ERK1/2 signaling; and forced-expression of reprogramming factors, e.g. 
Klf2, Klf4, Nanog or cMyc (Hanna et al. 2009b). 
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1.1.5.2 Human embryonic stem cells (hESCs) 
  In 1990s, hESC was derived by isolation and subsequent cultivation of ICM from 
blastocyst-staged IVF embryos (Figure 2) (Bongso et al. 1994;Lavoir et al. 
1998;Thomson et al. 1998). Because of their differentiation and self-renewal ability, 
hESCs were warmly received as a promising cell source for tissue engineering and 
regenerative medicine purposes. To date, more than 225 hESC lines have been 
generated and 75 lines are registered in the NIH Stem Cell Registry. 




Figure 2: Schematic diagram showing the derivation of hESCs. (Adopted from NIH 
Stem Cell Report 2006) 
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  Although hESCs are like mESCs and isolated from preimplantation embryos, they 
somehow share critical features with mouse EpiSCs: flattened morphology, low 
single-cell clonogenicity, inactivated X chromosome and pluripotency positively 
regulated by TGF-β/FGF2/Activin/ERK-1/2 singaling. Short term conversion of 
hESCs to a mESC-like state is possible. This conversion was achieved by the same 
method which is used to convert mouse EpiSCs to mESCs (Hanna et al. 2010). 
Interestingly, derivation of hESCs under physiological oxygen condition preserves the 
pre-X-inactivation chromosome status. Nevertheless, these activated X chromosomes 
have the tendency to undergo random inactivation after hESCs adopts to the in vitro 
culture condition (Lengner et al. 2010;Hanna et al. 2010). 
To date, maintenance of hESCs in a mESC-like state is still a challenge. There are 
justified motivations to obtain mESC-like hESCs. First, hESCs normally have low 
single-cell clonogenicity. This property restricts the use of hESCs in high-throughput 
disease-related and toxicology research. Second, hESCs have low gene targeting 
efficiency. Generation of hESCs which can be easily genetic modified will broaden 
their use in many areas. 
 
1.2 Cultivation of hESCs 
1.2.1 Cultivation of hESCs on mouse embryonic fibroblast (MEF) feeder cells 
  Mouse embryonic fibroblasts (MEFs) are normally required to maintain hESCs in 
the undifferentiated pluripotent state. MEFs are typically isolated from day 12.5-13.5 
mouse fetus. They secrete heparan sulfate proteoglycans, and growth factors such as 
pigment epithelium derived factor. These factors are either dissolved in culture 
medium or present in extra cellular matrix (ECM) (Xie et al. 2004; Levenstein et al. 
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2006). Segregated growth factors and ECM are generally believed as the key factors 
in MEFs that support undifferentiated growth of hESCs. Proteomic analysis of MEF-
conditioned medium revealed the abundance of proteins including: insulin-like 
growth binding protein (IGFBP)-4 related to cell differentiation and growth; 
metabolic enzymes include nucleoside diphosphate kinase A/B; cytoskeleton proteins 
including β-actin, lamin A/C; ECM and remodeling proteins including collagen IV, 
stromelysin-1; signaling transduction factors including growth factor receptor bound 
protein 2 (Lim and Bodnar 2002). 
  To elucidate the key factors that support hESC growth, the secretion of hESC-
supporting MEFs has been compared with non-hESC-supporting MEFs. The 
following chemical factors were found to be exclusively secreted in hESC-supporting 
MEFs: pigment epithelium derived factor (PEDF), IGFBP-5, AMDA25 and matrix 
metalloproteinase-14 (MMP14) (Chin et al. 2007). These factors are either related to 
cell growth and differentiation, or play a role in embryogenesis (Zhu et al. 
1999;Tombran-Tink and Johnson 1989;Houenou et al. 1999). Antibody-based protein 
array analysis showed that cytokines such as LIF-regulated monocyte chemoattractant 
protein (MCP)-1 and IL-6 were more abundant in condition media of hESC-
supporting MEFs (Ernst et al. 1996;Chin et al. 2007). LIF are known to positively 
regulate mESC pluripotency through the activation of LIF/gp130/STAT3 pathway. 
But LIF does not appear to maintain hESC pluripotency (Smith and Hooper 
1987;Okita and Yamanaka 2006;Thomson et al. 1998). IL-6 is also not responsible 
the pluripotency of hESCs, since murine IL-6 does not act upon human receptor. 
Meanwhile, it was reported that hESC-supporting MEFs secrete Activin A, TGFβ1 
and BMP-14, but not FGF2 (Eiselleova et al. 2008). This finding explained why extra 
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FGF2 must be supplemented to hESC culture medium in order to maintain 
pluripotency, even in the presence of MEFs. 
  Although MEFs are traditionally used as feeders for hESCs, they are also a source of 
contamination to the otherwise pure hESC population. In many cases, residual MEFs 
interfere with hESCs in population-averaging and cell-lysis-based laboratory 
procedures. For clinical applications, MEFs also increases the risk of introducing 
animal pathogens and viruses to patients (Cobo et al., 2008).  
 
1.2.2 Cultivation of hESCs on human feeder cells 
  Apart from MEFs, primary human cells can also be used to support hESCs growth. 
Reported human feeder cells include: fetal muscle fibroblast (Richards et al. 2002), 
adult abdominal skin fibroblast (Richards et al. 2003), adult bone marrow stromal 
cells (Cheng et al. 2003), foreskin fibroblast (Amit et al. 2003;Hovatta et al. 2003), 
uterine endometrium cells (Lee et al. 2005) and placenta fibroblast (Genbacev et al. 
2005). Using transcriptome and proteome analyses, hESC-supporting and non-hESC-
supporting human feeder cells have been compared. The results suggested a role of 
ECM components (collagen type I, III and V, fibronectin I, heparin sulfate 
proteoglycan II and hyaluronan synthase II) in the maintenance of pluripotency (Kueh 
et al. 2006;Prowse et al. 2005). 
  Moreover, autologous feeder cells derived from hESCs also have a checkered history. 
By using autologous feeders, biopsies of human tissues are no longer needed to obtain 
feeders. Reported autologous feeder cells are mostly fibroblast-like (Stojkovic et al. 
2005;Wang et al. 2007; Yoo et al. 2005). Some of these feeders have characteristics 
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similar to that of multipotent mesenchymal stem cells (Olivier et al. 2006;Lian et al. 
2007;Choo et al. 2008). 
 
1.2.3 Cultivation of hESCs under feeder-cell-free conditions 
  Feeder-cell-free hESC cultivation is a more straight forward and less labor-intensive 
than using feeder cells. One way to achieve feeder-cell-free is by cultivating hESCs 
on ECM-coated substrate. The most widely used ECM is probably Matrigel (Xu et al. 
2001). Matrigel is a protein mixture extracted from mouse Engelbreth Holm-Swarm 
sarcoma. It mainly contains laminin, collagen IV, fibronectin as well as heparin 
sulfate proteoglycans (Kleinman et al. 1982). Alternatively, ECM extracted from 
MEF was reported to support hESC culture (Klimanskaya et al. 2005). The main 
disadvantage of Matrigel and MEF-derived ECM is their animal and/or tumorous 
origin, which is not suitable for clinical applications of hESCs. 
  ECM regulates various biological functions including cell adhesion, migration, 
morphogenesis, etc (Hay 1991;Buck and Horwitz 1987;Hynes 1999;Geiger et al. 
2001). Chemically, ECM comprises of a network of macromolecules including 
glycosaminoglycans (GAG) and fibrous proteins. 
  Heparin sulfate of GAG usually links with protein and form proteoglycan. 
Proteoglycan plays a role in intracellular signaling and work in collaboration with cell 
surface receptors to mediate cellular responses to extracellular proteins, e.g. FGF 
binding and proliferation (Reiland and Rapraeger 1993). 
  Fibrous proteins organize the matrix and mediate cell attachment. For example, 
laminin promotes assembly of hESC colonies (Evseenko et al. 2009); fibronectin 
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triggers signal transduction that regulates hESC proliferation through integrin 
receptors (Amit et al. 2004;Braam et al. 2008). 
 
1.3 Applications of ESCs in toxicity studies 
  Use of ESCs in toxicity study has been envisioned since the early days of ESC 
research (Wobus and Boheler 2005;Davila et al. 2004;Guan et al. 1999). However, its 
implementation, especially with hESCs, has been constrained by both practical limits 
and bioethical considerations (Audrey et al. 1999). A pioneer example of such 
application is the embryonic stem cell test. 
 
1.3.1 Embryotoxicity and the embryonic stem cell test (EST) 
  Mouse ESCs have been used for embryotoxicity assessment of pharmaceutical 
compounds and environmental factors (Heuer et al. 1993;Festag et al. 2007;Festag et 
al. 2007). The involved technique, which is termed as the embryonic stem cell test 
(EST), relies on the ability of mESCs to differentiate into cardiomyocytes. 
Embryotoxicity is assessed by treating mESCs with testing compounds, and analyzing 
the proliferation and differentiation of mESCs into cardiomyocytes. Cell viability and 
inhibition of differentiation are some of the normally used endpoints. 
  The original EST has been improved since its invention. Over the years, statistical 
prediction model was developed for EST. Quantitative imaging techniques were 
adopted for data generation and analysis (Paparella et al. 2002). To validate the EST 
as standardized method for embryotoxicity evaluation, effectiveness of the assay was 
compared with animal studies and other in vitro embryotoxicity tests including rat 
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whole embryo culture and zebrafish embryotoxicity test (Scholz et al. 1999; de et al. 
2011a; de et al. 2011b; Genschow et al. 2004). Overall, available data suggest that a 
battery of in vitro assays, including EST, has the potential to predict embryotoxicity 
with relatively high accuraty. Predictivity of EST is superior to the rat whole embryo 
culture model, and next only to zebrafish embryotoxicity test among the available in 
vitro tests (de et al. 2011a;de et al. 2011b). 
 
1.3.2 Other toxicity study using ESCs 
  Apart from the assessment of embryotoxicity, ESCs have also been used to study 
other forms of toxicity. These include cytotoxicity of environmental factors such as 
cigarette smokes (Lin et al. 2010), pharmaceutical drug (Cao et al. 2008;Davila et al. 
2004), physical condition such as heat shock (Heng et al. 2006), genotoxicity of 
chemicals (Vinoth et al. 2008), as well as the toxicity of nanomaterials such as 
multiwalled carbon nanotubes (Zhu et al. 2007). 
 
1.4 Reactive oxidative species (ROS) 
  Although oxygen is important for aerobic life, it nevertheless becomes toxic when 
excessive amount of reactive oxygen species (ROS) is generated through metabolism 
(Girotti 1990;Floyd 1990;Agarwal et al. 2005). Oxidative stress occurs when the 
balance between ROS and antioxidants is disrupted and shifts towards excessive ROS. 
ROS rises from incomplete reduction of molecular oxygen. Some members and 
sources of ROS are: hydrogen peroxide (H2O2), free radical superoxide anion (O2-) 
and hydroxyl radical (OH-) (Baud and Ardaillou 1986). For research purposes, H2O2 
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can be used to effectively induces oxidative stress and toxicity (Yin et al. 2005;Du et 
al. 2006). H2O2 permeates membrane (Yin et al. 2005;Du et al. 2006) and causes 
deleterious effects in cells (Park et al. 2005;Liu et al. 2002;Lee et al. 2005;Dumont et 
al. 1999). 
  Low level of ROS is required for normal physiological functions of organisms. For 
example, oxidative stress has been identified as an important factor for the regulation 
of embryo development (Hausburg et al. 2005;Han et al. 2006;Burton et al. 2006). 
Nevertheless high level of ROS is cytotoxic, and induces various forms of cellular 
injury including lipid peroxidation as well as membrane damage. Apart from 
cytotoxicity, ROS also causes DNA damage including DNA single- and double-strand 
breaks in cells (Driessens et al. 2009). Moreover, ROS has been associated with 
carcinogenesis and many malignancies (Sun 1990;Ripple et al. 1997;Baker et al. 
1997). Lastly, oxidative stress also play a role in pathogenesis during the development 
of embryos (Kitagawa et al. 2004;Gutiérrez-Adán et al. 2004;Baker and Aitken 2005).  












Hypotheses and Objectives 




  Effective laboratory use of hESCs for toxicity research has been limited by technical 
hurdles that originate from hESC’s distinctive cell physiology. One major challenge is 
to exclude MEF feeder cells from the cultivation system of hESCs. It is hypothesized 
that effective cytotoxicity and DNA damage study can be enabled through the 
development of a feeder-cell-free hESC cultivation system. 
  Because of the drastically different cell physiologies between pluripotent hESCs and 
differentiated cells, it is also hypothesized that their cytotoxicity and DNA damage 




  The first objective is to establish an autologous feeder-cell-free cultivation system 
for the undifferentiated in vitro growth of hESCs.  This was pursued by extracting 
ECM from fibroblast-like cells and using the ECM-coated substrate for the cultivation 
of hESCs. 
  The second objective is to derive differentiated cells from hESCs. The differentiated 
progenies of hESCs were compared to hESCs for ROS-induced cytotoxicity and DNA 
damage. 
  The third objective is to study ROS-induced cytotoxicity and DNA damage on 
hESCs and their differentiated progenies, as well as the molecular mechanism behind 
the damage responses. 
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3.1 Cultivation of H9 hESCs 
  For this project, a NIH-registered hESC cell line, H9, was routinely maintained and 
expanded on inactivated MEF feeder cells. Before conducting cytotoxicity and DNA 
damage experiments, hESCs were transferred from MEFs to a feeder-cell-free, 
autologous ECM-supported culture system and cultured for >10 passages. 
 
3.1.1 Cultivation of H9 hESCs on MEFs 
  H9 hESCs were maintained on MEF feeder cells in 6-well plates (NUNC) with 
medium composed of DMEM/F12 (Gibco), 20% knockout serum replacement 
(Gibco), 4 ng/mL FGF2 (Invitrogen), 1 mM L-gluratime (Gibco), 1% non-essential 
amino acid (Gibco) and 0.1 mM β-mercaptoethanol. Medium was renewed on daily 
basis. Subcultivation was performed at about 80% cell confluency and by enzymatic 
dissociation of H9 colonies with 1 mg/mL collagenase IV (Gibco) for 5 minutes at 
37°C. H9 colonies were then mechanical dissection into clumps with a sterile pipette 
tip. The H9 clumps were centrifuged at 200×g for 5 minutes. H9 pellet was 
resuspended in fresh medium and seeded on to a new 6-well plate with inactivated 
MEFs. The MEFs were thawed from cryopreservation one day before hESC 
subcultivation and seeded on 0.1% gelatin (Sigma-Aldrich)-coated plates at 2.5×104 
cell/cm2. 
  Procedures for obtaining MEF feeder cells are described in the following sections 
from 3.1.1.1 to 3.1.1.3. 
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3.1.1.1 Derivation of MEFs by extraction of mouse embryos 
  Day 13.5 pregnant CF-1 mice were sacrificed by CO2 suffocation. Abdomens of 
mice were disinfected with 70% ethanol. Peritoneal walls were cut and uterine horns 
were exposed. Uterine horns were transferred to a Petri dish and washed twice with 
1×Ca2+/Mg2+-free phosphate buffered saline (PBS, 1st Base). Sacs were removed to 
release the embryos. Visceral tissues were separated from embryos with sterile 
surgical tools and discarded. Embryos were washed three times with PBS. After 
removal of excessive PBS, embryos were minced by fine iris scissors for 10-15 
minutes and completely dissected. 5 mL of 0.05% trypsin/EDTA (TE, Gibco) was 
added to the dissected embryos and followed by 10 minutes of incubation at 37°C. 
After vigorous pipetting, 5 mL of fresh TE was added to the minced tissues followed 
by incubation at 37°C for another 10 minutes. After the enzymatic digestion, 20 mL 
of MEF derivation medium (Table 1) were added to neutralize TE. The sludgy 
mixture was transferred to a 50 mL falcon tube and the tissues were pelleted by 
centrifugation at 300×g for 5 minutes. Supernatant was then removed. The tissue 
mixture was re-suspended in fresh MEF derivation medium and seeded in 75 cm2 
culture flasks (TPP) pre-coated with 0.1% gelatin. The seeding density was 3 embryos 
per flask. Derived MEFs were incubated at 37°C in a 5% CO2 atmosphere with 95% 
humidity. At 90% confluence, the MEFs were cryopreserved in MEF 
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3.1.1.2 Expansion of MEFs 
  Cryopreserved MEFs were thawed and plated in a 150 cm2 culture dish (TPP) and 
expanded in MEF expansion medium (Table 1) for 3-4 passages. The splitting ratios 
at subcultivation were 1:3-1:8, depending on cell condition. 
 
3.1.1.3 Mitotic inactivation and cryopreservation of MEFs 
  When >90% confluency of MEFs was reached in the 3rd or 4th passage, the cells 
were mitotic inactivated for 2 hours with 10 μg/mL mitomycin C (Kyowa) which was 
dissolved in Hank’s balanced salt solution (HBSS, Sigma-Aldrich). After inactivation, 
MEFs were harvested by trypsinization and cryopreserved at 1.4 × 106 cell/mL/vial in 
MEF freezing medium (Table 1). 
 
Table 1: Composition of media for MEF derivation. 
MEF derivation medium (1020 mL) 
Dulbecco’s Modified Eagle’s Medium (DMEM, Sigma-Aldrich) 900 mL 
Fetal Bovine Serum (FBS, Biowest) 100 mL 
Non-essential amino acid solution (Sigma-Aldrich) 10 mL 
Penicillin-Streptomycin 100x solution (Gibco) 10 mL 
MEF cryopreservation medium (100 mL) 
DMEM 70 mL 
FBS 20 mL 
Dimethyl sulfoxide (DMSO, Sigma-Aldrich) 10 mL 
MEF expansion medium (1010 mL) 
DMEM 900 mL 
FBS 100 mL 
Non-essential amino acid solution 10 mL 
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3.1.2 Cultivation of H9 hESCs in a feeder-cell-free condition with autologous 
ECM 
  Autologous ECM coating was obtained to enable feeder-cell-free cultivation of H9 
hESCs. The procedure for ECM extraction is described in section 3.1.2.1. 
  To initiate feeder-cell-free H9 hESC cultivation, an ECM-coated 6-well plate were 
removed from -20°C storage and sat in room temperature for 30 minutes. H9 colonies 
on MEFs were dissociated with 1 mg/mL collagenase IV for 5 minutes followed by 
mechanical dissection with a sterile pipette tip. Dissected small clumps of H9 were 
resuspended in TeSR2 animal protein-free maintenance medium for hESCs (Stemcell 
Technologies) and seeded on the ECM-coated plate. Medium was renewed on daily 
basis. When H9 reached about 80% confluency, subcultivation was performed by 
enzymatic dissociation of H9 colonies with 1 mg/mL dispase (Stemcell Technologies) 
for 7 minutes at 37°C. Dissociated H9 colonies were broken into small clumps by 
gentle pipetting, and then pelleted by centrifugation at 200×g for 5 minutes. H9 
clumps were resuspended in fresh TeSR2 medium and seeded on a new ECM-coated 
plate. Splitting ratios of feeder-cell-free H9 culture was kept at 1:6. 
 
3.1.2.1 ECM extraction 
  ECM was extracted from fibroblast-like cells (H9dF) which were derived from H9 
through cell differentiation. Procedures for obtaining H9dF are described in section 
3.2. 
  To perform ECM extraction, H9dF were seeded at 2.5×104 cell/cm-2 on a tissue 
culture plate pre-coated with 6 μg/cm2 human collagen IV (Sigma-Aldrich) in DMEM 
medium supplemented with10% fetal bovine serum (FBS). After overnight 
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attachment of the cells, the medium was replaced with ECM-deposition medium, 
which was composed of DMEM supplemented with 0.5% FBS, 50 μg/mL ascorbic 
acid (Sigma-Aldrich) and 100 μg/mL of dextran sulfate (Sigma-Aldrich). H9dF cells 
were cultured at 37°C for 3 days to allow deposition of ECM on the substrate. After 
ECM deposition, the plate was frozen with medium at -80°C overnight then thawed at 
room temperature. Medium was removed and the plate was rinsed with 1×PBS thrice 
to remove dead H9dF, before air-dried in the lamina flow cabinet. The ECM-coated 
plate was sealed with parafilm and stored at -20°C. (Figure 3) 
 
 
Figure 3: Schematic diagram showing the derivation of ECM. 
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3.1.2.2 Characterization of ECM composition by immunofluorescence staining 
and confocal microscopy 
  ECM was deposited on a glass chamber (Lab-Tek) and fixed by 4% 
paraformaldehyde. Fixed samples were washed twice with PBS for 5 minutes. 
Samples were then stained with primary antibodies with 1:200 dilutions in staining 
buffer (2% BSA/PBS) overnight at 4oC. IgG1 antibody (Santa Cruz Biotechnology) 
was used as isotype control. Samples were washed twice for 5 minutes with PBS 
supplemented with 0.05% Tween 20, followed by another 5-minute wash with PBS. 
They were then incubated with secondary antibodies with 1:200 dilutions in staining 
buffer for 2 hours at room temperature in the dark. Next, samples were washed twice, 
5 minutes each with washing buffer, followed by another wash with PBS for 5 
minutes. Images were captured with an Olympus Fluoview FV1000 confocal 
microscope. Final images were constructed and analyzed by FV10-ASW 2.0 Viewer 
software. 
  Primary antibodies: mouse anti-human collagen I (Santa Cruz Biotechnology), 
mouse anti-human collagen IV (Sigma-Aldrich), mouse anti-human collagen VI 
(Chemicon), rabbit anti-human fibronectin (Chemicon) and rabbit anti-human laminin 
(Chemicon). 
  Secondary antibodies: Alexa Fluor 488 conjugated goat anti-mouse IgG (Invitrogen), 
Alexa Fluor 594 conjugated goat anti-rabbit IgG (Invitrogen). 
 
3.2 Derivation of fibroblast-like cells H9dF from H9 hESCs 
  Fibroblast-like cells, designated as H9dF, were obtained through differentiation of 
H9 hESCs. The differentiation process went through several steps including: EB 
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formation in suspension culture, EB adhesion, further differentiation and expansion in 
adhesion culture. (Figure 4) 
 
 
 Figure 4: Schematic diagram showing the derivation of H9dF. 
 
3.2.1 Embryoid body (EB) formation 
  EBs were derived in a AggreWell 400 plate (Stemcell Technologies). To initiate EB 
formation, TeSR2 medium was removed from feeder-cell-free H9 cultured in a 6-well 
plate. Cells were rinsed twice with 2 mL of DMEM/F12. 750µL of accutase (Stemcell 
technologies) was then added to each well and followed by incubation for 10 minutes 
at 37°C. After incubation, detached H9 and floated H9 clumps were collected in a 15 
mL falcon tube. H9 clumps were broken by pipetting 3-5 times with a 1000 mL 
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micropipette. Single cells were obtained by running the H9 suspension through a cell 
strainer of 40 µM pore size (BD Falcon). H9 single cells were pelleted by 
centrifugation and then re-suspended in EB medium supplemented with 10 µM Y-
27632 Rho-associated protein kinase (ROCK) inhibitor (Stemcell technologies). 
Composition of EB medium was: DMEM/F12, 20% knockout serum replacement, 1 
mM L-glutamine, 1% non-essential amino acid and 0.1 mM β-mercaptoethanol. Cell 
number was counted with a hemocytometer. 1.2×106 cells were seeded in each 
AggreWell to generate uniform-sized EBs (1000 cells per EB). After cells were 
seeded, AggreWell was centrifuged at 100×g for 3 minutes to capture the cells at the 
bottom of microwells. After 24 hours of incubation at 37°C and 5% CO2, EBs were 
dislodged from the microwells by gentle pipetting. Harvested EBs were plated in 
ultra-low adherence 6-well plate (Corning) at about 1000 EB per well. EB medium 
without Y-2763 was renewed every 3 days. 
 
3.2.2 Differentiation of outgrown EBs in adhesion culture 
  After 5 days of suspension culture, two wells of H9 EB aggregates were collected 
and seeded on a 75 cm2 flask pre-coated with 0.1% gelatin-coated in DMEM+10% 
FBS differentiation medium. The medium was renewed 3 times a week. The 
differentiating cells were maintained in the initial passage for 2-3 weeks without 
subcultivation. This allowed extensive cell differentiation to take place. After 2-3 
weeks, differentiated cells were subcultivated periodically with 0.05% TE at 1:5 
splitting ratio, until cells became morphologically homogeneous. The derived cells 
were designated as H9dF for their spindle-shaped fibroblast-like morphology and H9 
origin. 
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3.3 Cell characterization 
3.3.1 Immunofluorescence staining of pluripotent markers 
  Expressions of pluripotency markers Oct-4, stage-specific embryonic antigen 
(SSEA)-4 and Tra-1-60 were examined by immunofluorescence staining. Cells were 
fixed with 4% paraformaldehyde at room temperature for 15 minutes. The samples 
were washed twice with PBS for 5 minutes each time, then permeabilized with 0.2% 
Triton-X in PBS for 10 minutes. Samples were blocked with PBS supplemented with 
5% normal goat serum (Vector Laboratories) and 2% bovine serum albumin (BSA, 
Sigma-Aldrich) for 1 hour at room temperature. The rest of the staining procedure 
followed the description in 3.1.2.2. Images were captured with an Olympus IX70 
fluorescence microscope. 
  Primary antibodies: Oct-3/4 (C-10) mouse monoclonal IgG2b (Santa Cruz 
Biotechnology), SSEA-4 mouse monoclonal IgG3 (Chemicon), Tra-1-60 mouse 
monoclonal IgM (Chemicon). 
  Secondary antibody: FITC conjugated goat-anti-mouse IgG (Santa Cruz 
Biotechnology). 
 
3.3.2 Teratoma formation 
  For teratoma formation, 3×106 cells were harvested and injected into 5-week old 
severe combined immunodeficiency (SCID) mice to initiate the assay. Mice were 
sacrificed 8 weeks after injection. Formation of teratoma was checked and clumps of 
teratoma were collected if observed. The teratoma samples were subjected to 
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histological processing. Hematoxylin and eosin (H&E) staining was performed as 
previously described (Lillie 1965). 
 
3.3.3 Karyotyping 
  Cells were blocked in metaphase by incubation with 7 ng/mL colcemid at 37ºC 
overnight. The treated cells were harvested and transferred to a 15 mL falcon tube for 
centrifugation. The supernatant was carefully aspirated, leaving behind approximate 
0.3 mL medium in tube. Then 5 mL of pre-warmed hypertonic solution (75 mM KCl) 
was slowly added to cell suspension with gentle vortexing. The cells were incubated 
in a 37ºC waterbath for 20 minutes and centrifuged. Supernatant was discarded, and 
cells were fixed by dropwise addition of 5 mL chilled methanol and acetic acid (3:1, 
v/v) into the tube. This fixation step was repeated 2 to 3 times. Fixed cells were aged 
for 2 weeks to allow better in situ hybridization later. To prepare metaphase spreads, 
few spots of cell suspension were dropped on a pre-cleaned slide. Slides were air-
dried and incubated over night at 65°C in an oven. Multi-color fluorescence in situ 
hybridization (mFISH) analysis was performed using Metasystems 24XCyte 
multicolor mFISH probe kit (Metasystems GmbH) following manufacturer’s 
instruction.  Images were captured with a Zeiss Axioplan microscope (Carl Zeiss 
GmbH) equipped with a cooled charged device (CCD) camera. ISIS FISH imaging 
software (Metasystems) were used for imaging capturing and data analysis. 
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3.4 Hydrogen peroxide (H2O2) treatment 
  H2O2 was used to induce ROS in cultivated cells. Working solutions of H2O2 with 
concentration ranging from 100 µM to 1000 µM were freshly prepared with 
DMEM/F12 basal medium immediately before use. Because H2O2 is known to be 
rapidly consumed in medium (Hampton and Orrenius 1997), freshly prepared 
working solution were renewed every hour for >1 hour H2O2 treatment. 
 
3.5 Detection of intracellular reactive oxygen species (ROS) 
3.5.1 MitoSOX Red mitochondrial superoxide staining 
  Stock solution of MitoSOX (5 mM) was prepared by dissolving 50 μg of MitoSOX 
mitochondrial superoxide indicator (Molecular Probes, Invitrogen) in 13 μL of DMSO. 
Before experiment, 5 μM MitoSOX working solution was freshly prepared by diluting 
5 mM stock solution with HBSS. Cells to be analyzed were cultivated in 6-well plate 
format. After treatment, medium containing H2O2 were removed. For each well, 1 
mL of MitoSOX working solution was added and incubated for 10 minutes at 37°C. 
After incubation, MitoSOX working solution was removed and the wells were washed 
3 times with warm 1×PBS. Cells were then supplemented with fresh medium and 
incubated at 37°C and 5% CO2 for 30 minutes to allow development of fluorescence. 
Images were captured with an Olympus IX70 fluorescence microscope. 
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3.5.2 DCFH-DA assay 
  Quantitative detection of intracellular ROS was performed with OxiSelect 
Intracellular ROS Assay Kit (Cell Biolabs). Before experiment, 1×DCFH-DA 
working solution was prepared by diluting 20×2',7'-dichlorfluorescein-diacetate 
(DCFH-DA) stock with DMEM/F12 basal medium. Cells to be analyzed were 
cultivated in a 96-well plate. Medium was removed and cells were washed twice with 
PBS. After washing, 100 µL of 1×DCFH-DA working solution was added to each 
well and incubated at 37oC for 60 minutes. DCFH-DA working solution was removed 
and cells were washed twice with PBS. DCFH-DA-loaded cells were treated with 
H2O2 for 30 minutes. After treatment, assay was terminated by addition of 100 µL of 
2×Cell Lysis Buffer provided by the kit. Contents in the wells were mixed by a shaker 
and incubated at room temperature for 5 minutes. 150 µL of the mixture from each 
well was transferred to a black-bottomed 96-well plate (NUNC). Fluorescence was 
read at 480 nm/530 nm with an Infinite 200 microplate reader (Tecan). Background 
fluorescence from wells without cells was deducted from each sample. Each sample 
was assayed in triplicates. Data were presented in fold induction of sample 
fluorescence over untreated control from the same cell type. 
 
3.6 Cytotoxicity assays 
3.6.1 MTS assay 
  3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-
tetrazolium, inner salt (MTS) cell viability assay was performed with CellTiter 96 
Aqueous One Solution Cell Proliferation Assay reagents (Promega). MTS working 
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solution was prepared by 1:6 dilution of stock with DMEM/F12 basal medium. Cells 
to be analyzed were cultivated in a 96-well plate. After treatment, medium with H2O2 
were removed. 120 µL/well MTS working solution was added to the cells and 
incubated at 37°C and 5% CO2 for 5 hours. Content in the wells was mixed on a 
shaker before analysis. Quantitative analysis was performed by reading absorbance at 
490 nm with an Infinite M200 microplate reader (Tecan). Absorbance value of cell-
free wells with only MTS working solution was deducted from each sample. Each 
sample was assayed in triplicates. Data were presented in percentage of sample 
absorbance over untreated control from the same cell type. 
 
3.6.2 EdU DNA synthesis assay 
  5-ethynyl-2´-deoxyuridine (EdU) DNA synthesis assay was performed with Click-iT 
EdU microplate assay reagents (Molecular Probes, Invitrogen). All reagents were 
thawed at room temperature and working solutions were prepared before experiment, 
following instruction of the manufacturer. Cells to be analyzed were cultivated in a 
96-well plate. After treatment, medium with H2O2 were removed. Cells were labeled 
with 10 µM EdU for 3 hours at 37°C and 5% CO2. After incubation, medium with 
EdU was removed. 50 µL/well of EdU fixative was added and incubated for 5 
minutes at room temperature. Subsequently, 50 µL/well of 2X reaction cocktail was 
added and incubated for 25 minutes at room temperature in the dark. Next, the 
reaction cocktail was removed and cells were washed twice with 200 µL/well 1X 
blocking buffer. After removal of wash buffer, 50 µL/well of working anti-Oregon 
Green HRP conjugate solution was added and incubated for 30 minutes at room 
temperature in the dark. After incubation, cells were washed twice with 200 µL/well 
Materials and Methods 
36 
 
Amplex UltraRed buffer. Wash buffer was removed from the well. 100 µL/well 
Amplex UltraRed reaction mixture was added and incubated for 15 minutes at room 
temperature in the dark. Finally, Amplex UltraRed stop reagent was added. 
Quantitative analysis was performed by reading fluorescence at 568 nm/581 nm with 
an Infinite 200 microplate reader (Tecan). Each sample was assayed in triplicates. 
Data were presented in percentage of sample fluorescence value over untreated 
control from the same cell type. 
 
3.6.3 Caspase-3/7 apoptosis assay 
  Caspase-Glo 3/7 (Promega, USA) assay measures enzymatic activity of caspase-3/7. 
The assay kit contains a proluminescent caspase-3/7 DEVD-aminoluciferin substrate, 
as well as a proprietary thermostable luciferase. The reagent is optimized for caspase-
3/7 and luciferase activity. Caspase-Glo 3/7 Reagent was added to one 96-well plate. 
Cell lysate was cleavaged of substrate by caspases. This freed aminoluciferin, which 
was consumed by luciferase and generated luminescence. Detection of luminescence 
was performed with an Infinite M200 microplate reader (Tecan). 
   
3.7 DNA damage assays 
3.7.1 Alkaline single cell gel electrophoresis (SCGE) 
  Cell to be analyzed were cultured in 60 cm2 tissue culture dishes (TPP). At the 
beginning of the experiment, culture medium was removed and cells washed three 
times with PBS to completely remove floating cells and debris before H2O2 treatment. 
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After treatment, cells were harvested either immediately for assay, or allowed 23.5 
hours of recovery in culture media before assay. 
  CometSlide (Trevigen) was cleaned by immersion in ethanol/1N hydrochloric acid 
(1:1) for 5 minutes, washing with tap water and drying with KimWipes. Lysis 
solution was chilled to 4oC. Low gelling temperature agarose (1% in distilled H2O, 
Sigma-Aldrich) was molten at 95 oC for 5 minutes then cooled down to 37 oC in a 
water bath.  H9 colonies were dissociated into single cells with Accutase (Stemcell 
technologies); H9dF and HEPM were harvest by trypsin-EDTA (Invitrogen). All cell 
samples were pelleted by centrifugation and resuspended at 1 x 105 cell/mL-1 in 1 x 
PBS. 50 µL of cell suspension was taken and mixed with 500 µL molten agarose. 
Subsequently, 50 µL of the cell/agarose mixture was transferred onto CometSlide 
(Trevigen) and spread evenly with micropipette tips. To allow gelling, slides were 
kept at 4oC in the dark for 20 minutes. The slides were subsequently immersed in 
chilled Lysis Solution (Trevigen) for 45 minutes at 4oC in the dark. After tapping off 
excessive Lysis Solution, slides were immersed in freshly prepared alkaline 
unwinding solution (200 mM NaOH, 1 mM EDTA in dH2O) for 45 minutes at RT in 
the dark. For electrophoresis, 500 mL chilled alkaline electrophoresis solution (200 
mM NaOH, 1 mM EDTA in dH2O) was added into an electrophoresis tank (Bio-Rad). 
All slides were placed equidistant from electrodes. Electrophoresis was performed at 
15 Volt for 30 minutes (constant voltage, current was kept around 300 mA by 
adjusting the volume of alkaline electrophoresis solution in the tank). Upon 
completion of electrophoresis, slides were removed from the tank and excessive 
solution tapped off. Slides were washed twice in distilled H2O then once in 70% 
ethanol before air dried. Each sample was stained with 100 µL SYBR Green I in TE 
buffer (pH 7.5) and air dried in the dark before image capturing. 
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  Images of representative cells were captured with an inverted fluorescence 
microscope (Olympus) using FITC filter at 200X magnification. Grayscale images 
were captured for quantitative analysis with the same microscope and filter set, but at 
40x magnification using 16 bit channel. Histograms of images were examined to 
ensure no overexposed pixels (>=255 intensity). Quantitative image analysis was 
performed with CometScore v1.5 software (TriTek) using tail moment as endpoint. 
Tail moment=tail length × % of DNA in the tail. Tail length was measured by number 
of pixels. Fifty cells were analyzed for each sample. 
 
3.7.2 H2AX Phosphorylation 
3.7.2.1 Immunofluorescence staining of γH2AX 
  The staining procedure followed the description in section 3.3.1. Confocal 
microscopic imaging and data analysis followed the description in section 3.1.2.2. 
FITC conjugated anti-γH2AX (Ser139) was used for staining (Chemicon).  
 
3.7.2.2 Quantification of γH2AX 
  Quantification of phosphorylated H2AX (γH2AX) was done by H2AX (Ser139) 
Dual Detect CELISA Assay Kit (Millipore). Cells to be analyzed were cultivated in a 
black-walled 96-well plate with transparent bottom and treated with H2O2. After 
treatment, cells were fixed by slowly adding 100 µL/well of fixation solution (95% 
ethanol, 5% acetic acid), and stand at room temperature for 7 minutes. After removal 
of the fixation solution, 100 µL/well of 1% formaldehyde in Tris-buffered saline 
(TBS), and stand at room temperature for 5 minutes. Each well was washed 3 time 
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with 200 µL wash buffer (2.0 mL of 20% Tween-20 and 40 mL of 20×TBS in 758 
mL distilled water). 100 µL of quenching buffer (0.4 mL 30% H2O2 in 11.6 mL of 
wash buffer) was added and incubated at room temperature for 20 minutes. Each well 
was washed 3 times with 200 µL wash buffer. 100 µL blocking buffer (3% BSA in 
wash buffer) was added and incubated for 1 hour at room temperature. Each well was 
washed 3 times with 200 µL wash buffer and incubated overnight at 4oC with 50 
µL/well anti-H2AX antibody and anti-γH2AX antibody mixture (1:500 dilution in 
blocking buffer). The next day, wells were washed 3 times with 200 µL wash buffer 
and incubated at room temperature with 100 µL/well goat anti-mouse HRP detection 
reagent and goat anti-rabbit AP detection reagent mixture (1:500 dilution in blocking 
buffer). Each well was washed twice with 200 µL wash buffer and once with 1×TBS. 
Samples were incubated for 30 minutes at room temperature with 100 µL HRP 
substrate and 200X AP substrate mixture (1:200 dilution). Fluorescence was read at 
550 nm/590 nm to detect γH2AX signal, then read at 360 nm/460 nm to detect total 
H2AX signals. All samples were analyzed in duplicates. Background fluorescence of 
no primary antibody controls was deducted from each sample. The γH2AX signals 
were normalized to total H2AX signal of the same well. Data were presented in 
percentage of sample fluorescence value over untreated control from the same cell 
type. 
 
3.8 Array-based real-time RT-PCR 
3.8.1 RNA extraction 
  RNA was extracted from cell using RNeasy Mini Plus Kit (Qiagen), following 
manufacturer’s instruction. Concentrations of RNA were determined with a Nanodrop 
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ND-1000 spectrophotometer (Nanodrop technologies). RNA samples were quality 
controlled by the following standards: A260:A230 ratio should be >1.7; A260:A280 
ratio should be between 1.8 and 2.0; concentration by A260 should be greater than 40 
mg/mL. 
 
3.8.2 Reverse transcription 
  Reverse transcription was performed using RT2 First Strand Kit (SABiosciences). 
For each sample, 1 µg RNA was supplemented with 5× gDNA Elimination Buffer 
and topped up to 10 µL with H2O2. The mixture was incubated at 42°C for 5 minutes 
then immediate chilled on ice for >1 minute. 10 µL of RT Cocktail (4 µL of 5×RT 
Buffer 3, 1 µL of Primer & External Control Mix, 2 µL of RT Enzyme Mix 3, and 3 
µL of water) was added to the mixture. The cDNA synthesis reaction was performed 
with a MyCycler thermal cycler (Bio-Rad) under the following condition: 42°C for 15 
minutes, 95°C for 5 minutes, holding at 4 °C. Upon completion, 91 µL of water was 
added to the 20 µL cDNA synthesis reaction mixture. The cDNA synthesis reaction 
mixture samples were stored at -20°C. 
  
3.8.3 Real-time RT-PCR 
  Human DNA Damage Signaling Pathway (PAHS-508C, SABiosicinece) and Human 
Cell Lineage Identification PCR array (PAHS-029C, SABiosicinece) were used for 
gene expression analysis. To carry out SYBR-Green-based real-time RT-PCR, 
experimental cocktail was prepared: 1350 µL of 2× RT2 qPCR Master Mix, 102 µL of 
cDNA synthesis reaction mixture, 1248 µL of water. 25 µL of the experimental 
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cocktail was aliquoted into each well of the 96-well format PCR array. PCR reaction 
was performed with a StepOnePlus Real-Time PCR machine (Applied Biosystems). 
The two-step cycling program in Table 2 was used to carry out polymerase chain 
reaction. 
 
Table 2: Two-step cycling program for real-time RT-PCR. 
Cycles Duration Temperature 
1 10 minutes 95oC 
40 15 seconds 95oC 
1 minute 60oC 
 
  For data analysis, the online RT² Profile PCR Array Data Analysis system 
(http://pcrdataanalysis.sabiosciences.com/pcr/arrayanalysis.php, SABiosciences) was 
used. GAPDH and β-actin were used as housekeeping genes. A gene is excluded for 
analysis if it had >30 threshold cycle in both sample and control. 
 
3.9 Statistical analysis 
  Statistical analysis was performed by GraphPad Prism Version 5.04 software. 
Statistical significance was evaluated by t-test, one-way ANOVA with Tukey's 
multiple comparison post test, or two-way ANOVA with Bonferroni multiple 
comparison post test. Difference was considered statistically significant if *p<0.05, 
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4.1 Derivation of fibroblast-like cells H9dF from H9 hESCs 
4.1.1 EB formation 
  To standardize EB sizes and increase the reproducibility of H9dF derivation 
procedure, AggreWell EB formation plates were used. By centrifuging 1.2×106 H9 
cells in AggreWell, H9 hESCs formed pellets at bottom of microwells (1000 
cells/pellet, 1200 microwells/plate) (Figure 5A, 5B). After overnight incubation in 
pellet form, H9 cells formed tight aggregates. The H9 aggregates were dislodged from 
bottom of the microwells and transferred to an ultralow attachment plate to initiate EB 
culture. Microscopic view showed the uniform-sized EB aggregates (Figure 5C, 5D).  
 
4.1.2 Outgrowth of EBs in adherent culture 
  After 5 days of suspension culture, H9 EBs became round in shape (Figure 6A). 
Fibroblast-like cells were obtained by plating the 5-day EBs on gelatin-coated plates, 
followed by further differentiation and proliferation in adherent culture. Spindle-
shaped cells became observable at the peripheral of EB outgrowth 2 days after cell 
attachment (Figure 6B). This fibroblast-like morphology became apparent after the 
first subculture and began to take over the entire cell population (Figure 6C). 






Figure 5: Formation of uniform EBs from H9 hESCs. (A) Microscopic view showing 
H9 pellets formed at the bottom of microwells. The scale bar indicates 500 µm. (B) 
Microscopic view showing H9 pellets at a higher magnification. The scale bar 
indicates 200 µm. (C) H9 aggregates formed by dislodging pellets from microwells. 
The scale bar indicates 500 µm. (D) Microscopic view showing H9 aggregates at a 







Figure 6: Derivation of fibroblastic-like cells H9dF from EBs. (A) Microscopic view 
showing the morphology of day-5 H9 EB. (B) Fibroblast-like cells appeared at 
boarders of EB outgrowth 2 days after cell attachment. (C) Fibroblast-like 
morphology became apparent after the first subculture. (D) Homogeneity of H9dF 








4.2 Characterization of H9dF-derived ECM 
  ECM was extracted from H9dF and used to support culture of undifferentiated H9. 
After the freeze-thaw process, live H9dF cells were removed by washing with PBS, 
leaving behind only ECM proteins attached to the cell culture substrate (Figure 7A). 
Composition of the ECM was characterized by immunofluorescence staining and 
confocal microscopy. ECM proteins were previously identified to contain collagen 
type I/IV/ VI, fibronectin and laminin fibrillar lattices  (Saylam et al. 2002;Beacham 
et al. 2007;Amenta et al. 1986). Consistent with these reports, collagen VI (Figure 
7B), fibronectin (Figure 7C) and laminin (Figure 7D) but not collagen I and IV were 





Figure 7: Characterization H9dF-derived ECM. (A) Phase-contrast microscopic image 
showing deposition of H9dF-derived ECM on the cell culture substrate. The scale bar 
indicates 100 µm. (B) Confocal microscopic imaging showing positive collagen VI 
staining of the ECM. (C) Confocal microscopic imaging showing positive fibronectin 
staining of the ECM. (D) Confocal microscopic imaging showing positive laminin 





4.3 Characterization of H9 hESCs and their differentiated progenies H9dF 
H9 was characterized after growing for >10 passages on autologous ECM. H9dF 
was characterized at the 10th passage. 
 
4.3.1 Morphology 
  Cell morphologies of H9, H9dF and HEPM were compared. H9 cultivated on 
autologous ECM (Figure 8B) grew in colonies and displayed a polarized epithelial 
cell morphology, which was similar to the conventional MEF-supported H9 (Figure 
8A). Morphology of H9dF was spindle-shaped, fibroblast-like (Figure 8C). The 
morphology of H9dF was similar to that of HEPM (Figure 8D) which is an 







Figure 8: Morphologies of H9 hESCs and their differentiated progenies H9dF. (A) H9 
cultivated on MEF feeder cells, and (B) H9 cultivated on autologous ECM, both grew 
in colonies and showed a polarized epithelial cell morphology. (C) H9dF shared a 
similar morphology with (D) HEPM, which was spindle-shaped and fibroblast-like.  
 
4.3.2 Proliferation 
  Proliferation of H9, H9dF and HEPM was compared by calculating cell population 
doubling time (Figure 9). Population doubling time of undifferentiated H9 (45.1 hours) 
was slightly shorter than H9dF (47.7 hours), but the difference was not statistically 
significant. The immortalized HEPM grew 2-3 times as fast as H9 and H9dF, and had 





Figure 9: Cell population doubling time of H9 and H9dF. H9 had slightly shorter 
population doubling time than H9dF, though the difference was not statistically 
significant. The population doubling time of HEPM was significantly shorter than 
either H9 or H9dF. *p<0.05, compared to HEPM. 
 
4.3.3 Pluripotency 
  To examine if H9 cultivated on autologous ECM maintained pluripotency, and if 
H9dF lost pluripotency and committed into somatic cell lineages, the expressions of 
pluripotency markers Oct-4, SSEA-4 and Tra-1-60 were examined by 
immunofluorescence staining.  H9 colonies were positively stained for all three 
pluripotency markers, whereas H9dF and HEPM showed negative staining for these 






Figure 10: Immunofluorescence staining of pluripotent markers. H9 was positively 
stained for Oct-4, SSEA-4 and Tra-1-60, whilst H9dF cells were negatively stained. 
Non-pluripotent HEPM cells with known differentiated status were used as negative 
control. The scale bars indicate 500 µm. 
 
  To verify the immunofluorescence staining results, in vivo teratoma formation assay 
was performed. Because of bioethical concerns, it is impossible to test germline 
transmission with hESCs. As a result, teratoma formation is widely accepted as the 
gold standard to test the pluripotency of human cells (Thomson et al. 1998). Eight 
weeks after H9 hESC injection, teratoma was formed in the left hind leg of the SCID 
mouse (Figure 11A). The teratoma was about 3.0 cm × 4.4 cm in size (Figure 11C). 





Figure 11: Teratoma formation. (A) Teratoma formed in the left hind leg of SCID 
mouse with H9 injection. (B) No teratoma was formed in the SCID mouse with H9dF 
injection. (C) Size of teratoma harvested from H9-injected SCID mouse was about 3.0 
cm × 4.4 cm. 
 
  Histological analysis of H9 teratoma was carried out to examine lineage identity of 
the tissues. Tissues from three germ layers (ectoderm, mesoderm and endoderm) were 
found in the H9 teratoma (Figure 12). These include ectopic formation of neural 
rosettes from ectoderm (Figure 12A), glandular epithelium from endoderm (Figure 
12B), cartilage (Figure 12C) and smooth muscle (Figure 12D) from mesoderm. 
  Taken together, the results from immunofluorescence staining and teratoma 
formation demonstrated that autologous ECM-supported H9 remained pluripotent, 






Figure 12: Histological analysis of H9 teratoma by H&E staining. (A) Neural rosettes 
from ectoderm. (B) Glandular epithelium from endoderm. (C) Cartilage from 
mesoderm. (D) Smooth muscle from mesoderm. The scale bars indicate 100 µm. 
 
4.3.4 Developmental status and lineage identity of H9dF 
  To further identify the developmental status and lineage identity of H9dF, mRNA 
gene expression analysis was conducted by array-based real-time RT-PCR. The panel 
of genes includes markers for pluripotency, three germ layers, progenitors and 
terminally differentiated cells. Expression of these genes in H9dF was compared with 
HEPM. 
  Figure 13 showed the scatter plot comparison of these genes between H9dF and 




and 17 genes were downregulated for <-2 folds (Figure 13). Table 3 summarized cell 
lineages represented by individual gene, together with values of fold regulation (Table 
3). Notably, germ layer markers ZIC1 and GATA6 were highly upregulated in H9dF 
(>100 fold regulation). Meanwhile, no terminal differentiation marker was 
upregulated in H9dF; instead 6 terminal differentiation markers were found to be 
downregulated in H9dF. This result suggests that H9dF shared some identity with 








Figure 13: Scatter plot comparing H9dF with HEPM for the expression of cell lineage 
identification genes. Boundary was set at 2 folds. One dot represents one gene. 
Upregulated genes appear as red dots and downregulated genes appear as green dots. 








Table 3: Summarization of lineage identification genes that were differentially 
expressed in H9dF and HEPM. Red-colored values indicate >2 folds upregulation; 







NANOG 3.54 pluripotent marker 
PODXL 13.27 pluripotent marker 
POU5F1 4.61 pluripotent marker 
DNMT3B 3.50 pluropotent marker 
FGF5 21.31 germ layer, ectoderm 
ZIC1 111.22 germ layer, ectoderm 
GBX2 2.88 germ layer, neuroectoderm 
BMP4 9.37 germ layer, mesoderm 
CD34 -4.03 germ layer, mesoderm 
GATA2 2.84 germ layer, mesoderm 
HAND1 5.41 germ layer, mesoderm 
IGF2 -30.84 germ layer, mesoderm 
PDGFRA -4.08 germ layer, mesoderm 
SOX2 2.42 germ layer, mesoderm 
GATA6 855.36 germ layer, endoderm 
MSLN 4.83 progenitor, ectoderm, limbal progenitor 
FOXG1 3.73 progenitor, ectoderm, moter neuron progenitor 
MAP3K12 2.81 progenitor, endoderm, hepatic stem cell 
KRT19 3.96 progenitor, endoderm, pancreatic islet cell 
HAND2 50.07 progenitor, mesoderm 
DPP4 47.06 progenitor,endoderm, hepatic stem cell 
AQP1 8.02 terminal differentiation,  mesoderm, chondrocytes 
COL10A1 23.63 terminal differentiation,  mesoderm, chondrocytes 
GAD1 7.10 terminal differentiation, mesoderm GABA neuron 
MYL3 6.11 terminal differentiation, mesoderm, cardiomyocytes 
NPPA 4.37 terminal differentiation, mesoderm, cardiomyocytes 
DCN 4.20 terminal differentiation, mesoderm, osteoclast 







  It was previously reported that under the stressed in vitro culture condition, hESCs 
tends to develop chromosomal abnormality over time (Imreh et al. 2006). The mFISH 
karyotyping was performed to examine the chromosomal status of ECM-supported 
H9 and their progenies H9dF. It was found that both H9 and H9dF, as well as HEPM 




Figure 14: Karyotyping. Normal 46,XX diploid karyotypes were found in (A) H9, (B) 
H9dF and (C) HEPM. The top row shows metaphase spreads, the bottom row shows 
karyograms. 
 
4.4 Intracellular ROS 
  Before the cytotoxicity and DNA damage were studied, it was first examined that if 




4.4.1 MitoSOX Red staining 
  Cellular superoxide was examined by MitoSOX Red staining. MitoSOX is live-cell 
permeable and selectively detects superoxide but not by other ROS or reactive 
nitrogen species (Estévez et al. 1998). 
  Cells were about 80% confluent at the beginning of the experiment. H9, H9dF and 
HEPM were treated with 100 µM or 1000 µM of H2O2 for 30 minutes. The 
dosage/time combinations were empirically determined in a pilot study with reference 
to previous reports. The combinations generate detectable ROS while causing 
minimal cell detachment immediately after treatment. After treatment, cell cultures 
were examined under microscope to ensure no cell detachment occurred. 
Fluorescence imaging of MitoSOX-Red-loaded cells revealed production of 
superoxide anion in H9, H9dF and HEPM (Figure 15). Qualitative imaging of 
MitoSOX Red suggested that H9 might be most sensitive to H2O2-mediated 
superoxide induction, which was indicated by the brightest red fluorescence in H9 
(Figure 15). To determine if intracellular ROS is indeed most highly induced in H9, 






Figure 15: Fluorescence microscopic images of MitoSOX Red.  Superoxide anion 
production post H2O2 treatment was reported by MiSOX Red fluorescence. All 
images were captured at a fixed exposure time. The scale bards indicate 500 µm. 
 
4.4.2 DCFH-DA assay 
  Intracellular ROS level was quantitatively analyzed by measuring fluorescence 
intensity of 2’, 7’-Dichlorodihydrofluorescein (DCF). DCFH-DA is a cell-permeable 
fluorogenic probe. After incubation, it diffuses into cells and is deacetylated into a 
non-fluorescent product by cellular esterases. The non-fluorescent product is rapidly 
oxidized by ROS into highly fluorescent DCF. Intensity of DCF fluorescence is direct 





  To induce intracellular ROS, H9, H9dF and HEPM were treated following the same 
schedule described in MitoSOX Red staining in section 4.4.1. Cell cultures were 
examined under microscope before fluorescent dye extraction to ensure no cell 
detachment occurred. 
  All three tested cell types showed increased intracellular ROS after treatment 
(p<0.01). H9 was the most sensitive among all (Figure 16A, 16B). Induction of DCF 
fluorescence in H9 (over untreated H9) was 2.1 folds at 100 µM H2O2 and a 9.6 folds 
at 1000 µM H2O2. Fold induction of DCF fluorescence in H9 was significantly higher 
than HEPM at both H2O2 dosages (p<0.05 at 100 µM, p<0.001 at 1000 µM). H9dF 
had the lowest fold induction of ROS after H2O2 treatment (Figure 16B). Induction of 
DCF fluorescence in H9dF (over untreated H9dF) was 1.1 fold at 100 µM H2O2 and a 
1.5 fold at 1000 µM H2O2. Induction of DCF fluorescence in H9dF was significantly 








Figure 16: DCFH-DA assay of intracellular ROS. Increased intercellular ROS was 
observed after H2O2 treatment. (A) Fluorescence microscopic imaging showing DCF 
fluorescence in extracted cells. Images were captured with a fixed exposure time. 
Brightness of green DCF fluorescence is proportional to intracellular ROS level. (B) 





4.5 H2O2-induced cytotoxicity 
  H2O2-induced viability loss was determined by MTS cell assay and DNA synthesis 
inhibition by EdU assay. 
 
4.5.1 Cell viability loss determined by MTS assay 
  MTS can be enzymatically reduced by metabolically active cells to a colored 
formazan product. The formazan product is soluble in cell culture medium in the 
presence of phenazine methosulfate (PMS) (Cory et al. 1991). Enzymatic activity was 
quantified by measuring absorbance of the colored formazan. 
  H9, H9dF and HEPM were treated with 100 µM or 1000 µM of H2O2 for 30 
minutes. Cell cultures were examined under microscope before fluorescent dye 
extraction to ensure no extensive cell detachment occurred. 
  All tested cells showed reduced cell viability after H2O2 treatment (p<0.001). For 
H9, percentage viability (over untreated H9) was 93.7% at 100 µM H2O2 and 53.6% 
at 1000 µM H2O2 (Figure 17). Viability of H9 was higher than HEPM at 100 µM 
H2O2 (p<0.01), but became lower than HEPM at 1000 µM H2O2 (p<0.05). For H9dF, 
percentage viability (over untreated H9dF) was 80.2% at 100 µM H2O2 and 73.6% at 







Figure 17: MTS viability assay. Cells were untreated, treated with 100 µM or 1000 
µM H2O2. *p<0.05, **p<0.01. 
  
4.5.2 DNA synthesis by EdU assay 
  Direct measurement of DNA synthesis is another way to evaluate cytotoxicity of 
H2O2. Nucleoside analog EdU is an alternative to bromo-deoxyuridine (BrdU). It 
incorporate into DNA during DNA synthesis. Detection of EdU allows measurement 
of DNA synthesis activity. 
  H9, H9dF and HEPM were treated with 100 µM or 1000 µM of H2O2 for 30 
minutes, followed by EdU labeling and fluorescence detection. Fluorescence and 
phase-contrast microscopic images of the cells (Figure 18) were captured before 




  All tested cells showed decreased DNA synthesis after H2O2 treatment (p<0.001). 
H9 was extreme sensitive to H2O2-induced DNA synthesis inhibition. DNA synthesis 
activity of H9 dropped to 22.8% of its untreated control at 100 µM H2O2, and further 
down to 8.9% at 1000 µM H2O2 (Figure 19). Compared with HEPM, the inhibition in 
H9 was significantly stronger at 100 µM and 1000 µM H2O2 (p<0.001). Inhibition in 
H9dF was 72.3% at 100 µM H2O2and 68.3% at 1000 µM H2O2. Compared with 
HEPM, the inhibition in H9dF was significantly weaker at 1000 µM H2O2 (p<0.05).  
 
Figure 18: Fluorescence and phase-contrast microscopic imaging of EdU-loaded cells 




1000 µM of H2O2; the inhibition effect was weaker in H9dF. Phase-contrast images 
showed no observable cell detachment. 
 
 
Figure 19: DNA synthesis in H2O2-treated cells measured with EdU. ***p<0.001. 
 
  It was demonstrated through MTS and EdU assays that 30 minutes of H2O2 
treatment at 100 µM and 1000 µM induced cytotoxicity. The treated cells were 
cultivated for another 24 hours in medium without H2O2 after treatment. It was found 
that H9, H9dF and HEPM treated with 1000 µM H2O2 eventually detached from the 
plate. However H9, H9dF and HEPM treated with 100 µM H2O2 remained attached. 
With regard to this finding, the sub-lethal dosage of 100 µM H2O2 was selected for 





  Cell apoptosis was studied by caspase-3/7. Caspase family proteins are one of the 
major executors of cell apoptosis (Nicholson and Thornberry 1997). Caspase-3 and 7 
are effector caspases responsible for cleavage of key cellular proteins leading to 
apoptotic phenotype. 
  H9, H9dF and HEPM were treated with 100 µM H2O2 for 4 hours followed by 
incubation with caspase-3/7. This treatment schedule led to increased caspase level in 
all tested cells (p<0.001). H9 was most sensitive of the three. Induction of caspase 
was 3.2 folds in H9, which was significantly higher than HEPM (p<0.001). Fold 
induction of caspase was 1.6 fold in H9dF, which was not significantly different from 
HEPM (Figure 20). 
 
 




4.7 DNA damage 
  To study H2O2-induced DNA damage, two assays were performed. Alkaline SCGE 
was used to study the global DNA damage and repair. Phosphorylation of H2AX was 
used to report DNA double-strand breaks (DSBs) which is a more specific yet severe 
form of DNA damage. 
 
4.7.1 Alkaline single cell gel electrophoresis (SCGE) 
  Under alkaline electrophoresis condition (pH >13), SCGE detects various forms of 
DNA damage including DSBs, single-strand breaks and alkali-labile sites. 
  H9, H9dF and HEPM were treated with 100 µM H2O2 for 30 minutes and subjected 
to alkaline SCGE either immediately or after 23.5 hours of recovery in media. Cells 
produced comet-like tail after treatment, which was indication of DNA damage; the 
comet-like tails became less apparent after recovery, which was indication of DNA 
repair (Figure 21). There was no significant difference in tail moment among 
untreated H9, H9dF and HEPM at both 0.5 hour and 24 hour time points (p>0.05) 
(Figure 22). H2O2 treatment led to increased tail moment in all tested cell types 
(p<0.001). Tail moment of H9 was 7.8 pixels immediately after treatment, and was 
significantly lower than HEPM (p<0.001). Tail moment of H9 was also significantly 
lower than H9dF immediately after treatment (p<0.001). For H9dF, tail moment was 
11.2 pixels after treatment. This was significantly lower than HEPM (p<0.05). After 






Figure 21: Fluorescence imaging of SYBR-Green stained cell nucleus after alkaline 
single cell electrophoresis (SCGE). Untreated cells displayed minimal DNA damage 
which was depicted by the round head nuclear morphology. H2O2-treated cells 
produced comet-like tails which was indication of DNA damage. Recovered cells had 






Figure 22:  Alkaline single cell gel electrophoresis immediately after H2O2 treatment 
or after 23.5 hours of recovery. The error bars indicate standard error. **p<0.01, 
***p<0.001. 
 
4.7.2 Phosphorylation of H2AX 
  Histone H2AX protein is a member of the H2A family histones. It is distinguished 
from other H2A histones with its unique carboxy-terminal sequence. This sequence is 
highly conserved in eukaryotic evolution (Madigan et al. 2002) and is rapidly 
phosphorylated by ATM/ATR at the 4th residue from carboxy-terminus (Serine 139) 
in response to DNA DSBs (Rogakou et al. 1998). Phosphorylated-H2AX (γH2AX) is 





  In this experiment, H9, H9dF and HEPM were treated with100 µM H2O2 for 4 hours. 
To examine H2O2-induced DSBs, a cell-based ELISA assay was used to detect 
γH2AX. Phosphorylated H2AX were normalized to total H2AX of the same sample. 
Another set of the same samples was prepared on glass chambers for 
immunofluorescence staining with γH2AX antibody (Figure 23). 
 
 
Figure 23: Immunofluorescence staining and confocal microscopic imaging of 
γH2AX. Images were captured for samples of untreated and cells treated with 100 µM 
H2O2. Res fluorescence shows γH2AX loci; blue fluorescence shows DAPI counter 
staining of nucleus. Fluorescence images were merged with light microscopic images. 





  Increased γH2AX was found in all tested cells with H2O2 treatment (p<0.05). 
Induction of γH2AX was 1.48 fold in H9, 1.86 fold in H9dF and 1.44 fold for HEPM 
(Figure 24). Fold induction of γH2AX was significantly higher in H2O2-treated H9dF 
in comparison with others treated cells (p<0.05). 
 
  
Figure 24: Quantification of γH2AX. Increased γH2AX levels were observed in all 
three cell types with H2O2 treatment. **p<0.05. 
 
4.8 Gene expression analysis 
  To understand the molecular mechanism behind the observed toxicity responses, 
mRNA gene expression analysis was performed with array-based real-time RT-PCR. 
A panel of 84 genes related to cell cycle arrest and signaling, apoptosis, and DNA 




  First, intrinsic expression levels of untreated H9 and H9dF were compared with 
HEPM. Second, H2O2-induced gene expression change was examined in H9, H9dF 
and HEPM. 
 
4.8.1 Genes expression profiles  
  For H9, the global pattern of gene expressions showed difference from HEPM 
(Figure 25A). Out of 84 genes that were analyzed, 28 genes were upregulated for >2 
folds, and 9 genes downregulated for <-2 folds. These differentially regulated genes 
have known functions in cell cycle arrest and checkpoint, apoptosis, and various DNA 
repair pathways. Specific functions of these genes and their fold regulations are 
summarized in Table 4. 
  For H9dF, the global pattern of gene expressions showed similarity to HEPM. This 
was demonstrated by closely clustered dots in the scatter plot (Figure 25B). Totally 80 
genes were analyzed. Out of these, only 3 genes were upregulated for >2 folds, and 2 
genes downregulated for <-2 folds. Specific functions of these 5 genes and their fold 







Figure 25: Scatter plot for the expression of DNA damage signaling genes. Boundary 
was set at 2 folds. Each dot represents one gene. Upregulated genes appear as red dots 
and downregulated genes appear as green dots. Triplication was used for each sample. 
 




Table 4: Summarization of DNA damage signaling genes that were differentially 
regulated in H9 and H9dF. HEPM served as control. Red-colored values indicate >2 
folds upregulation; Green-colored values indicate <-2 folds downregulation with the 






GADD45G 129.55 <2 apoptosis 
IP6K3 18.50 <2 apoptosis 
AIFM1 4.40 2.28 apoptosis 
GADD45A 4.13 5.78 apoptosis 
PCBP4 3.64 <2 apoptosis, cell cycle arrest 
PPP1R15A 4.08 <2 apoptosis, cell cycle arrest 
RAD21 2.06 <2 apoptosis, double strand break repair 
TP73 9.42 <2 apoptosis, mismatch repair 
NTHL1 3.06 <2 base excision repair 
UNG 8.69 <2 base excision repair 
MUTYH 6.27 <2 base excision repair, mismatch repair 
CHEK2 7.70 <2 cell cycle arrest 
MAP2K6 8.07 <2 cell cycle arrest 
SESN1 3.41 <2 cell cycle arrest 
DDIT3 3.86 <2 cell cycle arrest 
MAPK12 2.73 <2 cell cycle arrest 
ZAK 5.62 <2 cell cycle arrest 
RAD1 3.66 <2 cell cycle checkpoint, damaged DNA binding 
DMC1 8.63 <2 damaged DNA binding 
RAD51 2.27 <2 damaged DNA binding 
SEMA4A 23.44 <2 damaged DNA binding 
XRCC2 3.00 <2 damaged DNA binding 
FEN1 2.76 <2 damaged DNA binding, DSB repair 
N4BP2 6.11 <2 damaged DNA binding, mismatch repair 
MSH2 9.55 <2 damaged DNA binding, mismatch repair 
MRE11A 4.98 <2 double strand break repair 
PRKDC 2.61 <2 double strand break repair 
RAD50 2.22 <2 double strand break repair 
CIB1 2.48 <2 double strand break repair 
EXO1 2.14 <2 mismatch repair 
MLH3 17.34 5.76 mismatch repair 
PMS1 3.80 <2 mismatch repair 
TREX1 3.81 3.92 mismatch repair 
ATRX <2 2.21 other 
CDK7 2.46 <2 other 
GTF2H2 2.36 <2 other 
LIG1 2.12 <2 other 





4.8.2 Expression of cell cycle arrest and checkpoint-related genes 
  It was found that 11 genes related to cell cycle arrest and checkpoint had 
significantly higher expression in H9, in comparison with differentiated H9dF or 
HEPM. These 11 genes are: ATR, CHEK1, CHEK2, FANCG, MAP2K6, RAD1, 
RAD9A, RAD17, RBBP8, SESN1 and SMC1A. (Figure 26) 
 
Figure 26: Expression of cell cycle arrest and checkpoint-related genes. *p<0.05, 
**p<0.01, ***p<0.001. 
 
4.8.3 Expression of apoptosis-related genes 
  It was found that 7 genes related to apoptosis signaling had significantly higher 
expression in H9, in comparison with differentiated H9dF or HEPM. These 7 genes 





Figure 27: Expression of apoptosis-related genes. *p<0.05, **p<0.01, ***p<0.001. 
 
4.8.4 Expression of DNA double-strand break repair genes 
  Six genes related to DNA double-strand break had significantly higher expression in 
H9, in comparison with differentiated H9dF or HEPM. These 6 genes are: FEN1, 





















5.1 Bioethical issues and rationalization of hESC research 
  Stem cell research has been receiving attention from both general public and 
scientific community. This status can perhaps be attributed to the unique relationship 
among ESCs, healthcare and origin of life. From a pure science point of view, ESCs 
were initially derived as a tool for developmental biology studies. Through gene 
knockout studies, mESCs became a powerful tool to study gene function in mammals. 
Later, successful derivation of hESCs generated renewed interest in regeneration 
medicine, cell therapy and tissue engineering. 
  Despite great enthusiasm of many medical doctors and biologists, hESC research 
faced inertia because of bioethical controversies. The debate has been focusing on 
whether hESC derivation is a process that destroys life. Most of the existing hESC 
cell lines were derived from to-be-discarded IVF embryos which were considered 
unsuitable for in vitro fertilization purpose. To obtain ICM tissues, embryos were 
surgically processed and their anatomical morphology was destroyed. However, 
biological contents of embryos continue to prosper in the form of cultivated hESC. 
Judging the ethical merit/disgrace of the hESC derivation procedure requires the very 
definition of life, which is too daunting of a subject to discuss in the context of this 
dissertation. 
  Although dust has yet to be settled for this bioethical debate, one possible conclusion 
would be: hESC research attempts to improve living conditions of human beings. At 
the end of the day, hESC research may still be judged by whether or not it will 





5.2 Regenerative medicine, tissue engineering and potential therapeutic 
applications of hESCs 
  Two directions are generally pursued in order to improve human health condition 
with hESCs. The first is through exploiting the differentiation capability of hESCs 
and producing engineered tissue replacements which can be used for cell therapies. 
This branch of stem cell research is often categorized under regenerative medicine or 
tissue engineering. Successful cell therapies would have to rely on the convergent 
advancement of different disciplines, including cell biology, material science, and 
construct technology. So questions like tissue regeneration and  integration of graft 
and host may eventually be solved (Audrey et al. 1999;Vacanti and Vacanti 
2007;Nerem 2007). 
  An earlier achievement of regenerative medicine is the bone marrow transplantation 
therapy. It was initially introduced in the 1950s to cure hematopoietic failure. 
Hematopoietic stem cell transplantation (HSCT) using alternative cell sources such as 
peripheral blood (Kessinger et al. 1989) or umbilical cord blood (Broxmeyer et al. 
1989) followed. And these cell were also adopted to treat other malignancies (Hobbs 
et al. 1981;Mahmood et al. 2007). For hESC-based therapies, US Food and Drug 
Administration (FDA) so far has approved several clinical trials targeting at treating 
severe spinal cord injuries. Among the many blockades that bottleneck the 
regeneration medicine pipeline, morphogenesis is one major challenge (Othmer et al. 
2009;Nerem 2007): from a clumps of hESCs, how to create tissue/organ replacements 
that recapitulate the morphology and function of native tissues? Notably, tissue 
patterning is shortcircuited and irrelevant in the case of HSCT: grafted cells are 




spatiotemporal intercellular coordination. But in general, tissue regeneration demands 
organization of cells into structures that imitate native tissues (Nerem 2007). 
  Because we are yet to fully elucidate how symmetry is broken and the body plan 
created in biological systems, tissue scaffolding (Yarlagadda et al. 2005;Cima et al. 
1991) becomes a stopgap measure to circumvent morphogenesis and a shortcut to 
three-dimensional (3D) morphologies. Scaffolding technologies draw on the 
biological sciences and know-how from the medical device industry. Conventionally 
made of synthetic biomaterials, scaffolds dictate positional information and passively 
lock down stem cells and growth factors at specific loci. On the downside, the 
available fabrication technologies sometimes fall short in attempts to recreate intricate 
microstructures (Nichol and Khademhosseini 2009). Another particular concern is 
biocompatibility. Examples of scaffold-related biocompatibility issues are: toxicity of 
degradation biomaterials, fibrous tissue formation and graft-host mechanical property 
mismatch (Williams 2008). These drawbacks prevent scaffolding from being a 
universal solution for tissue patterning. 
  Alternatively, stem cell-derived tissue/organ replacements can be constructed in a 
scaffold-free manner through modular tissue engineering. Unlike the “top-down” 
philosophy behind the scaffolding approach, modular tissue engineering builds 
biological structures from the bottom up (Nichol and Khademhosseini 2009). 
Tissue/organ-specific architecture is realized through the fabrication of modular units 
(Mironov et al. 2003;Yeh et al. 2006;Dean et al. 2007) and subsequent assembly of 
the parts (McGuigan et al. 2006;Du et al. 2008). Successful cases of such endeavors 
are found in engineered skin and blood vessels. For skin, its multilayer sheet-like 
structure can be achieved by overlaying keratinocytes on dermal equivalents that 




structures can be bioprinted from digital blueprints, using cell aggregates as 
microscale building blocks and agarose rods as molding guides (Norotte et al. 2009). 
Exclusion of scaffolds relieves biocompatibility issues caused by the use of synthetic 
materials. But mechanisms of pattern formation remain drastically different between 
engineered and physiologically generated tissues/organs. 
  Native tissues/organs are built through morphogenesis during embryogenesis or 
physiological regeneration. In morphogenesis, positional information is resolved by 
intrinsic mechanisms perhaps involving biochemical signatures, e.g. bone 
morphogenetic protein (BMP) gradients (Shimmi et al. 2005) and differential Hox 
gene expressions (Chang et al. 2002;Rinn et al. 2008); whereas spatial coordination of 
current generation engineered tissues is mostly predetermined with anatomic and 
histological data of native tissues. In another word, engineered tissues generally do 
not acquire shape and geometry through a homeostatic biological process; positional 
information is superimposed on constituent cells instead. As a consequence, their 
structural integrity and mechanical strength may become inferior to native 
tissues/organs, e.g. engineered blood vessels that are prone to mechanical failure 
because of thin wall and low burst pressure (McKee et al. 2003;Poh et al. 2005). 
  The question of whether it is possibility for stem cells to autonomously self-organize 
into complex tissues/organs like a developing embryo has been raised (Gordon 1999). 
Because of their unsurpassed developmental potential and normal chromosomal status, 
it would be reasonable to nominate ESCs as a probable candidate to test for self-
patterning capability. But unlike a developing embryo, conventional wisdom has it 
that ESCs do not undergo morphogenesis in the in vitro context. On the bright side, 
this avoids the potential ethics dilemma of raising conscious, human babies in Petri 




morphogenic capability may be subjected to several interpretations. It is possible that 
at the blastocyst stage, the ICM that produces ESCs has already specialized to the 
point that potency to self-organize is lost. Alternatively, existing ESC differentiation 
protocols may not have catered to the dynamic niche required for morphogenesis. 
  Encouragingly, Eiraku et al. experimentally showed that mouse ESCs self-organized 
into a 3D architecture mirroring optic cup (retinal primordium) in both morphology 
and molecular characteristics (Eiraku et al. 2011). As described in their study, ocular 
patterns emerged from outer surface of ESC aggregates following a series of 
temporally sequenced morphogenic events, namely the evagination of optic vesicles, 
invagination of neural retina (NR) and sorting/stratification of NR cells. Meanwhile, 
the morphogenesis was accompanied by sequential bifurcations of each cell’s 
molecular identity, e.g. the rise of Rx-positive retinal progenitors from Rx-negative 
ESCs, and specialization of retinal progenitors to either NR or retinal pigment 
epithelium. That sophisticated morphogenesis originates in vitro from an ESC culture 
is unprecedented. Even though this is only partial organogenesis, as illustrated by the 
absence of lens, surface ectoderm and perhaps choroid fissure, this phenomenal 
finding nevertheless suggests that self-organization capability is somewhat preserved 
and retrievable in ESCs. Whilst it exciting to envisage a new generation of self-
assembly tissue/organ replacements, Eiraku et al. described the observed patterning as 
“unanticipated” and governed by a “latent intrinsic order”, suggesting the lack of a 
complete mechanistic understanding of the process. 
  It is apparent that successful therapeutic application of hESC is challenging because 
of ethical, safety and efficacy issues (Illes et al. 2011;Lo and Parham 2010). But it 
nevertheless holds the potential to treat some of the most devastating diseases in 




including fundus flavimaculatus and age-related macular degeneration. Although a 
reminder should be put on that understanding the basic physiology and developmental 
biology of ESCs is important. Without the support of such knowledge, translational 
hESC research will be relying solely on trails and errors in the laboratory to meet the 
clinical demands. 
 
5.3 Non-therapeutic application of hESCs in toxicity study 
  Apart from the development of novel therapies, hESCs may also indirectly improve 
healthcare. For example, hESCs may be used to screen toxicity of compounds and 
safety of drugs. In this study, we exploited ROS production and ROS-induced 
cytotoxicity and DNA damage with hESCs, and gain some understanding on hESC’s 
unique toxicology properties. 
  The first step of this project was to remove a major technical hurdle that limits the 
use of hESC in toxicology research: contamination from MEF feeder cells. To 
exclude MEFs from hESCs, a feeder-cell-free hESC cultivation system was 
developed. It was demonstrated that H9 hESCs can be effectively cultivated on 
autologous ECM without losing its pluripotency and normal chromosomal status. The 
feeder-cell-free cultivation system allowed properties of hESCs to be effectively 
studied without influence from feeder cells. Because the ECM was derived from 
autologous fibroblast-like cells (H9dF), it also avoided possible introduction of 
allogeneic human proteins. 
  By using feeder-free-cultured hESCs, ROS-induced cytotoxicity and DNA damage 
were analyzed with hESCs. H2O2 treatment was used as a method to effectively 




with H9 hESC and its differentiated fibroblast-like cells H9dF. H9dF served as a cell 
model to gauge the toxicity responses of differentiated cells. Because H9 and H9dF 
shared the same genetic background and had similar growth speed, their toxicological 
response can be directly compared. HEPM, an immortalized human fibroblast cell 
line with known origin from embryonic palate, was used as control throughout this 
study. HEPM was chosen because it had a checkered record for the screening of 
environmental teratogens (Pratt et al. 1982). 
  It was found through proliferation assay that HEPM grew 2-3 times as fast as H9 and 
H9dF. The highly proliferative nature signified the cell’s immortalized status. 
Karyotyping revealed that H9, H9dF and HEPM had normal diploid chromosome sets. 
Unlike H9, the differentiated H9dF and HEPM did not express typical pluripotency 
markers Oct-4, SSEA-4 and Tra-1-60. This result confirmed H9dF and HEPM as 
models for differentiate cells. Because H9dF was derived in-house, its developmental 
status and cell lineage identity was further examined by mRNA gene expression 
analysis. H9dF had unregulated germ layer and progenitor marker. It suggests that 
H9dF is immature compared with terminally differentiated HEPM. 
  As introduced in the literature review section, ROS plays a role in both physiological 
and pathological aspects of embryo development (Hausburg et al. 2005;Han et al. 
2006;Burton et al. 2006). In this study, it was found that ROS production was highly 
induced in H9 hESCs compared with H9dF and HEPM. This might be attributed to 
the high metabolic activity of hESCs (Kang et al. 2009). With H2O2-induced ROS 
production, cell viability loss was found in H9, H9dF and HEPM. Interestingly, 
inhibition of DNA synthesis appeared to be the greatest in H9. This DNA synthesis 




  Next, alkaline SCGE assay was applied to assess the DNA damage. Among all 
tested cells, H9 hESCs had least among of DNA damage immediately after H2O2 
treatment. Further assessment showed that DNA DSB marker γH2AX was most 
highly upregulated in H9dF, suggesting that DSB might be more readily repaired in 
undifferentiated hESCs. 
  This unique damage response of H9 hESCs can be partially explained by 
upregulated expression of cell cycle arrest/checkpoint, apoptosis, and DNA damage 
signaling genes. It was found untreated H9 had higher expression of many DNA 
damage signaling genes (Table 4). Notably, one of the most highly upregulated genes, 
GADD45G, is known to have high expression in embryonic tissues (Suzuki et al. 
1999). It was found that genes involved in damaged DNA binding and DSB repair 
(e.g. RAD51, RAD51L1, XPA) were upregulated solely in H9 but not in 
differentiated cells (Table 4) (Missura et al. 2001;Katagiri et al. 1998;Hussain et al. 
2004). Meanwhile, genes involved in DSB repair (BRCA1, XRCC2, RAD18, 
PRKDC) were downregulated only in H2O2-treated H9dF (Table S1). 
Downregulation of these genes may help explain the relatively high γH2AX level in 
H9dF. 
  It may be argued that the distinct ROS damage response found in hESCs may be a 
mechanism for early embryo to maintain its genome integrity. From the point of 
evolution, mammals must undergo long pregnant period to produce few offspring. 
Because of the high investment in reproduction, stringent quality control of the 
embryo is done at early stage to reduce sunk cost and to gain advantage in natural 
selection. A “fail early and fail cheap” philosophy may apply here. Indeed, mammals 
have developed mechanisms such as abortion to prematurely terminate pregnancy if 




selection seemed to be found in hESCs, as they deploy a two folds mechanisms to 
control embryo quality: first, excludung severely damaged cells through apoptosis; 
second, rescue mildly damaged cells by cell cycle arrest and active DNA repair. 
  Another noteworthy point for translation stem cell research is that undifferentiated 
hESCs could be a suitable model for cytotoxicity screening because of their high 
sensitivity. To the contrary, differentiated cells might be more suitable for genetic 
toxicity testing, because DNA damage is more readily detectable since repair activity 
is slower.
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  In summary, the autologous ECM system enabled feeder-cell-free cultivation of 
undifferentiated hESCs. By excluding MEF feeder cells from hESC culture, many 
population-averaging and lysis-based assays could be effectively conducted without 
introducing MEF contamination. Taking advantage of this cultivaion system, 
cytotoxicity and DNA damage manifested by H2O2-induced ROS were examined in 
hESCs and differentiated cells. Results suggest that intracellular ROS were highly 
induced by H2O2 in hESCs, in comparison to differentiated cells. While both hESCs 
and differentiated cells displayed loss of viability after H2O2 treatment, DNA 
synthesis was more strongly inhibited in hESCs. This strong inhibition of DNA 
synthesis was accompanied by greater induction of apoptosis. Despite that, level of 
DNA damage was lower in hESCs in comparison to differentiated cells. This result 
might be an indication of more rapid DNA repair in hESCs. Compared to pluripotent 
hESCs, it was also found that DSBs, a severe form of DNA damage, was more readily 
induced in hESC-derived fibroblast cells. The observed damage responses could be 
partly attributed to high expression of DNA damage signaling genes in hESCs, and 
relatively retarded DNA repair activity in the differentiated cells. 
  For future studies, expression of DNA damage/repair genes could be studied at 
protein level. This effort would help piece together a more complete picture for the 
unique damage responses in hESCs. 
  Although acute toxicity of H2O2 was studied in this project, it would be meaningful 
to know the long-term impact of ROS on embryonic tissue development and 
pathophysiology. Such study may be realized by using hESCs as a model to mimic 
embryo development, possibly through EB cultivation. Another challenge is to find a 
method to introduce stable physiological level of ROS in cell culture for long time, 
since H2O2 is unstable and not suitable for chronic toxicity study. 
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  Moreover, for toxicology especially high throughput toxicity screening, hESC 
cultivation system can be further improved with upscalable cultivation methods, e.g. 
3D cultivation on microcarriers (Chen et al. 2010), chemical or physical modification 
of substrate (Wang et al. 2009). Advancement in these areas may greatly improve the 
current limited status of hESC-based toxicology research. 
  Last but not the least, it would be interesting to see if hESC cell lines with mESC-
like high single-cell clonogenicity can be derived and efficiently maintained in vitro 
(Hanna et al. 2010). If successful, technical procedures to handle hESCs could be 
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1. List of genes for PCR array 
Cell Cycle:  
Cell Cycle Arrest: CHEK1, CHEK2, DDIT3 (CHOP), GADD45A, GML, GTSE1, 
HUS1, MAP2K6, MAPK12, PCBP4, PPP1R15A, RAD17, RAD9A, SESN1, ZAK.  
Cell Cycle Checkpoint: ATR, BRCA1, FANCG, NBN (NBS1), RAD1, RBBP8, 
SMC1A (SMC1L1), TP53.  
 
Apoptosis: ABL1, BRCA1, CIDEA, GADD45A, GADD45G, GML, IHPK3, PCBP4, 
AIFM1 (PDCD8), PPP1R15A, RAD21, TP53, TP73.  
 
DNA Repair:  
Damaged DNA Binding: ANKRD17, BRCA1, DDB1, DMC1, ERCC1, FANCG, 
FEN1, MPG, MSH2, MSH3, N4BP2, NBN (NBS1), OGG1, PMS2L3 (PMS2L9), 
PNKP, RAD1, RAD18, RAD51, RAD51L1, REV1 (REV1L), SEMA4A, XPA, XPC, 
XRCC1, XRCC2, XRCC3.  
Base-excision Repair: APEX1, MBD4, MPG, MUTYH, NTHL1, OGG1, UNG.  
Double-strand Break Repair: CIB1, FEN1, XRCC6 (G22P1), XRCC6BP1 (KUB3), 
MRE11A, NBN (NBS1), PRKDC, RAD21, RAD50.  
Mismatch Repair: ABL1, ANKRD17, EXO1, MLH1, MLH3, MSH2, MSH3, 
MUTYH, N4BP2, PMS1, PMS2, PMS2L3 (PMS2L9), TP73, TREX1.  
Other Genes Related to DNA Repair: APEX2, ATM, ATRX, BTG2, CCNH, CDK7, 





2. Expression DNA damage signaling genes after H2O2 treatment 
  Expression of the DNA damage signaling genes were compared before and after 
H2O2 treatment. H9, H9dF and HEPM were exposed to 100 µM H2O2 for 4 hours. 
Samples were then harvest for gene expression analysis. 
  For H2O2-treated H9, 11 genes were upregulated for >2 folds and 1 gene 
downregulated for <-2 folds (Figure S1). Specific functions and fold regulation of 
these genes were summarized in Table S1. 
 
Figure S1: Scatter plot comparing the expression of DNA damage signaling genes in 
H9 before and after H2O2 treatment. Boundary was set at 2 folds. Each dot represents 
one gene. Upregulated genes appear as red dots and downregulated genes appear as 




  For H2O2-treated H9dF, 10 genes were upregulated for >2 folds and another 10 
different genes downregulated for <-2 folds (Figure S2). Specific functions and fold 
regulation values of these genes were summarized in Table S1. 
 
Figure S2: Scatter plot comparing the expression of DNA damage signaling genes in 
H9dF before and after H2O2 treatment. Boundary was set at 2 folds. Each dot 
represents one gene. Upregulated genes appear as red dots and downregulated genes 





  For H2O2-treated HEPM, 9 genes were upregulated for >2 folds and 2 genes 
downregulated for <-2 folds (Figure S3). Specific functions and fold regulation values 
of these genes were summarized in Table S1. 
 
Figure S3: Scatter plot comparing the expression of DNA damage signaling genes in 
HEPM before and after H2O2 treatment. Each dot represents one gene. Upregulated 
genes appear as red dots and downregulated genes appear as green dots. Triplication 




Table S1: Summarization of DNA damage signaling genes regulated by H2O2 
challenge. Red-colored values indicate >2 folds upregulation; Blue-colored values 




H9 H9dF HEPM 
CIDEA <2 4.57 <2 apoptosis 
GADD45A 8.19 9.41 10.88 apoptosis 
GADD45G <2 3.74 <2 apoptosis 
IP6K3 <2 <2 14.02 apoptosis 
PPP1R15A 4.26 6.15 5.19 apoptosis, cell cycle arrest 
BRCA1 <2 -3.78 <2 apoptosis, cell cycle checkpoint, damaged DNA binding 
DDIT3 19.93 10.89 21.20 cell cycle arrest 
SESN1 <2 10.55 8.95 cell cycle arrest 
CHEK1 <2 -2.25 <2 cell cycle arrest 
GTSE1 <2 -9.52 -2.95 cell cycle arrest 
MAP2K6 <2 <2 -2.26 cell cycle arrest 
RBBP8 2.37 <2 <2 cell cycle checkpoint 
SMC1A <2 -2.04 <2 cell cycle checkpoint 
FANCG <2 -2.89 <2 cell cycle checkpoint, damaged DNA binding 
XPC <2 2.74 3.04 damaged DNA binding 
RAD18 <2 -2.28 <2 damaged DNA binding 
RAD51 4.23 <2 <2 damaged DNA binding 
RAD51L1 2.30 <2 <2 damaged DNA binding 
XPA 4.12 <2 <2 damaged DNA binding 
XRCC2 <2 -2.73 <2 damaged DNA binding 
PMS2L3 2.48 <2 <2 damaged DNA binding, mismatch repair 
PRKDC <2 -2.92 <2 double strand break repair 
XRCC6BP1 -2.33 <2 <2 double strand break repair 
TREX1 2.20 2.54 2.52 mismatch repair 
EXO1 <2 -3.87 <2 mismatch repair 
BTG2 4.26 23.95 21.10 other 
PCNA 2.31 2.38 3.85 other 
LIG1 <2 -2.19 <2 other 
 
 
 
  
